JP5571073B2 - Ｓ１ｐ１受容体作働薬およびその使用 - Google Patents

Info

Publication number

JP5571073B2

JP5571073B2 JP2011514619A JP2011514619A JP5571073B2 JP 5571073 B2 JP5571073 B2 JP 5571073B2 JP 2011514619 A JP2011514619 A JP 2011514619A JP 2011514619 A JP2011514619 A JP 2011514619A JP 5571073 B2 JP5571073 B2 JP 5571073B2

Authority

JP

Japan

Prior art keywords

fluoro

phenyl

thiazolo

pyridin

phenylcyclopropyl

Prior art date

2008-06-20

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired - Fee Related

Links

• Espacenet
• Global Dossier
• Discuss

• 102000011011 Sphingosine 1-phosphate receptors Human genes 0.000 title claims description 28
• 108050001083 Sphingosine 1-phosphate receptors Proteins 0.000 title claims description 28
• 229940044601 receptor agonist Drugs 0.000 title description 6
• 239000000018 receptor agonist Substances 0.000 title description 6
• -1 monosubstituted amino Chemical group 0.000 claims description 374
• 125000000217 alkyl group Chemical group 0.000 claims description 225
• 150000001875 compounds Chemical class 0.000 claims description 177
• OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 153
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 131
• 229920006395 saturated elastomer Polymers 0.000 claims description 96
• 229910052799 carbon Inorganic materials 0.000 claims description 83
• 229910052731 fluorine Inorganic materials 0.000 claims description 70
• 125000001188 haloalkyl group Chemical group 0.000 claims description 68
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 68
• 229910052739 hydrogen Inorganic materials 0.000 claims description 64
• 229910052801 chlorine Inorganic materials 0.000 claims description 62
• 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 49
• 125000001153 fluoro group Chemical group F* 0.000 claims description 40
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 38
• 229910052757 nitrogen Inorganic materials 0.000 claims description 38
• 125000004181 carboxyalkyl group Chemical group 0.000 claims description 35
• GFZWHAAOIVMHOI-UHFFFAOYSA-N azetidine-3-carboxylic acid Chemical compound OC(=O)C1CNC1 GFZWHAAOIVMHOI-UHFFFAOYSA-N 0.000 claims description 34
• 239000002253 acid Substances 0.000 claims description 33
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 33
• 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 claims description 28
• 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 27
• 229910052717 sulfur Inorganic materials 0.000 claims description 21
• 125000006583 (C1-C3) haloalkyl group Chemical group 0.000 claims description 20
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 20
• 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 19
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 19
• 150000003839 salts Chemical class 0.000 claims description 19
• 229910052760 oxygen Inorganic materials 0.000 claims description 18
• 125000000753 cycloalkyl group Chemical group 0.000 claims description 17
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 17
• 239000001257 hydrogen Substances 0.000 claims description 16
• 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 15
• 125000004103 aminoalkyl group Chemical group 0.000 claims description 14
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 14
• 150000001721 carbon Chemical group 0.000 claims description 13
• 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 12
• 125000000623 heterocyclic group Chemical group 0.000 claims description 11
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 11
• 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 10
• 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 10
• 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 9
• 201000010099 disease Diseases 0.000 claims description 9
• 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 9
• 125000004011 3 membered carbocyclic group Chemical group 0.000 claims description 8
• 125000004429 atom Chemical group 0.000 claims description 8
• 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 8
• 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 7
• 125000001845 4 membered carbocyclic group Chemical group 0.000 claims description 7
• 125000001054 5 membered carbocyclic group Chemical group 0.000 claims description 7
• 125000004008 6 membered carbocyclic group Chemical group 0.000 claims description 7
• 125000001960 7 membered carbocyclic group Chemical group 0.000 claims description 7
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
• 125000005113 hydroxyalkoxy group Chemical group 0.000 claims description 7
• 230000001404 mediated effect Effects 0.000 claims description 7
• KCMALGDZUKTGJR-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 KCMALGDZUKTGJR-UHFFFAOYSA-N 0.000 claims description 6
• 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 6
• 125000004442 acylamino group Chemical group 0.000 claims description 6
• NQOYFWVJUAMDSC-UHFFFAOYSA-N 1-[[2-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound CC1=CC(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)=CC=C1CN1CC(C(O)=O)C1 NQOYFWVJUAMDSC-UHFFFAOYSA-N 0.000 claims description 5
• RSJXHKBDHLDTJG-UHFFFAOYSA-N 1-[[3-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C=1C=C(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)C(C)=CC=1CN1CC(C(O)=O)C1 RSJXHKBDHLDTJG-UHFFFAOYSA-N 0.000 claims description 5
• 125000004663 dialkyl amino group Chemical group 0.000 claims description 5
• 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims description 4
• UMQXIFJBTRLNCD-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-[1-(4-hydroxyphenyl)cyclopropyl]-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC(O)=CC=3)N=C2S1 UMQXIFJBTRLNCD-UHFFFAOYSA-N 0.000 claims description 4
• LWFNPYNEZMTEHO-UHFFFAOYSA-N 2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]propan-2-amine Chemical compound FC1=CC(C(C)(N)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 LWFNPYNEZMTEHO-UHFFFAOYSA-N 0.000 claims description 4
• OSOQQWGQWAAXRR-UHFFFAOYSA-N 3-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]cyclobutane-1,1-dicarboxylic acid Chemical compound C1C(C(=O)O)(C(O)=O)CC1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 OSOQQWGQWAAXRR-UHFFFAOYSA-N 0.000 claims description 4
• WFIHKLWVLPBMIQ-UHFFFAOYSA-N [1,3]thiazolo[5,4-b]pyridine Chemical compound C1=CN=C2SC=NC2=C1 WFIHKLWVLPBMIQ-UHFFFAOYSA-N 0.000 claims description 4
• 125000002431 aminoalkoxy group Chemical group 0.000 claims description 4
• 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims description 4
• 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 4
• 125000004475 heteroaralkyl group Chemical group 0.000 claims description 4
• 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 claims description 4
• OHDAURMSEHMPFJ-IBGZPJMESA-N (1s)-2,2,2-trifluoro-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanol Chemical compound FC1=CC([C@H](O)C(F)(F)F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 OHDAURMSEHMPFJ-IBGZPJMESA-N 0.000 claims description 3
• IXHZVOWTEVMNQD-UHFFFAOYSA-N 1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]cyclopropan-1-amine Chemical compound C=1C=C(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)C(F)=CC=1C1(N)CC1 IXHZVOWTEVMNQD-UHFFFAOYSA-N 0.000 claims description 3
• OIQUGXZGFRNXRR-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclohexyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CCCCC3)C=3C=CC=CC=3)N=C2S1 OIQUGXZGFRNXRR-UHFFFAOYSA-N 0.000 claims description 3
• XOISWOAQHPFMSU-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopentyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CCCC3)C=3C=CC=CC=3)N=C2S1 XOISWOAQHPFMSU-UHFFFAOYSA-N 0.000 claims description 3
• KBRHOHMPEPDZJP-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]-3-hydroxyazetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)(O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 KBRHOHMPEPDZJP-UHFFFAOYSA-N 0.000 claims description 3
• WYDTUIYHKYBKDQ-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-[1-(4-fluorophenyl)cyclopropyl]-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC(F)=CC=3)N=C2S1 WYDTUIYHKYBKDQ-UHFFFAOYSA-N 0.000 claims description 3
• NZOPMUNLWDQQBS-UHFFFAOYSA-N 2-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]propane-1,3-diol Chemical compound FC1=CC(CC(CO)CO)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 NZOPMUNLWDQQBS-UHFFFAOYSA-N 0.000 claims description 3
• 239000005973 Carvone Substances 0.000 claims description 3
• RSJARRDGCGLARB-UHFFFAOYSA-N [3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methanol Chemical compound FC1=CC(CO)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 RSJARRDGCGLARB-UHFFFAOYSA-N 0.000 claims description 3
• 150000007513 acids Chemical class 0.000 claims description 3
• 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 3
• 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 claims description 3
• DFKVJJCSINDUMY-SFHVURJKSA-N (3s)-1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]pyrrolidine-3-carboxylic acid Chemical compound C1[C@@H](C(=O)O)CCN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 DFKVJJCSINDUMY-SFHVURJKSA-N 0.000 claims description 2
• KVSCIJUANFKDHN-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclobutyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CCC3)C=3C=CC=CC=3)N=C2S1 KVSCIJUANFKDHN-UHFFFAOYSA-N 0.000 claims description 2
• OIIKLYFYHWVBBT-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopent-3-en-1-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC=CC3)C=3C=CC=CC=3)N=C2S1 OIIKLYFYHWVBBT-UHFFFAOYSA-N 0.000 claims description 2
• SJRVYCQTDNRXSQ-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidin-3-ol Chemical compound C1C(O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 SJRVYCQTDNRXSQ-UHFFFAOYSA-N 0.000 claims description 2
• QFXSDFZFPKZDSK-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(2-phenyloxetan-2-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(OCC3)C=3C=CC=CC=3)N=C2S1 QFXSDFZFPKZDSK-UHFFFAOYSA-N 0.000 claims description 2
• XQLGIFYJCJXYBJ-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-[1-(2-fluorophenyl)cyclopropyl]-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C(=CC=CC=3)F)N=C2S1 XQLGIFYJCJXYBJ-UHFFFAOYSA-N 0.000 claims description 2
• ZKOGVNKSMKCWIJ-UHFFFAOYSA-N 2-[4-[(3,3-difluoroazetidin-1-yl)methyl]-2-fluorophenyl]-5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound C=1C=C(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)C(F)=CC=1CN1CC(F)(F)C1 ZKOGVNKSMKCWIJ-UHFFFAOYSA-N 0.000 claims description 2
• ASUCRXBDHDVRQF-UHFFFAOYSA-N 2-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzoyl]amino]acetic acid Chemical compound FC1=CC(C(=O)NCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ASUCRXBDHDVRQF-UHFFFAOYSA-N 0.000 claims description 2
• YBBIQAQUTJCVHA-UHFFFAOYSA-N 3-[2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]propan-2-ylamino]propanoic acid Chemical compound FC1=CC(C(C)(NCCC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 YBBIQAQUTJCVHA-UHFFFAOYSA-N 0.000 claims description 2
• LAXZWYOIVOOUDB-UHFFFAOYSA-N 3-[[1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]cyclopropyl]amino]propanoic acid Chemical compound C=1C=C(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)C(F)=CC=1C1(NCCC(=O)O)CC1 LAXZWYOIVOOUDB-UHFFFAOYSA-N 0.000 claims description 2
• 125000004539 5-benzimidazolyl group Chemical group N1=CNC2=C1C=CC(=C2)* 0.000 claims description 2
• CFJDEAYMRZMDGQ-IYARVYRRSA-N C1[C@@H](C(=O)O)C[C@@H]1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 Chemical compound C1[C@@H](C(=O)O)C[C@@H]1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 CFJDEAYMRZMDGQ-IYARVYRRSA-N 0.000 claims description 2
• CFJDEAYMRZMDGQ-HDICACEKSA-N C1[C@H](C(=O)O)C[C@@H]1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 Chemical compound C1[C@H](C(=O)O)C[C@@H]1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 CFJDEAYMRZMDGQ-HDICACEKSA-N 0.000 claims description 2
• CIFFBENAZAIHLL-UHFFFAOYSA-N [2,6-dimethyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methanol Chemical compound CC1=C(CO)C(C)=CC(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)=C1 CIFFBENAZAIHLL-UHFFFAOYSA-N 0.000 claims description 2
• DLKFRHULCKAHOW-UHFFFAOYSA-N [2-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methanol Chemical compound C1=C(CO)C(C)=CC(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)=C1 DLKFRHULCKAHOW-UHFFFAOYSA-N 0.000 claims description 2
• 125000001072 heteroaryl group Chemical group 0.000 claims description 2
• UWAASNKMOLMYQX-UHFFFAOYSA-N 3-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]cyclobutane-1-carboxylic acid Chemical compound C1C(C(=O)O)CC1NC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 UWAASNKMOLMYQX-UHFFFAOYSA-N 0.000 claims 2
• HPLPYWLCVPJOBA-CQSZACIVSA-N (1r)-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanamine Chemical compound FC1=CC([C@H](N)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 HPLPYWLCVPJOBA-CQSZACIVSA-N 0.000 claims 1
• HPLPYWLCVPJOBA-AWEZNQCLSA-N (1s)-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanamine Chemical compound FC1=CC([C@@H](N)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 HPLPYWLCVPJOBA-AWEZNQCLSA-N 0.000 claims 1
• ICAUQGOTJWRMLA-OAQYLSRUSA-N (2r)-1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1CCN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ICAUQGOTJWRMLA-OAQYLSRUSA-N 0.000 claims 1
• LGXUOJNGDSKUJR-JOCHJYFZSA-N (2r)-1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@H]1CCCN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 LGXUOJNGDSKUJR-JOCHJYFZSA-N 0.000 claims 1
• GRHYDNFYDMAIFI-OAHLLOKOSA-N (2r)-2-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methylamino]propanoic acid Chemical compound FC1=CC(CN[C@H](C)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 GRHYDNFYDMAIFI-OAHLLOKOSA-N 0.000 claims 1
• KMCSQCGFOWMHTE-GOSISDBHSA-N (2r)-2-amino-3-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]propanoic acid Chemical compound FC1=CC(C[C@@H](N)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 KMCSQCGFOWMHTE-GOSISDBHSA-N 0.000 claims 1
• VTWSHDBNPHFDGO-RUZDIDTESA-N (2r)-2-amino-4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]-2-methylbutanoic acid Chemical compound FC1=CC(CC[C@](N)(C)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 VTWSHDBNPHFDGO-RUZDIDTESA-N 0.000 claims 1
• MLIPKGLXHUBXKK-LJQANCHMSA-N (2r)-2-amino-4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]butanoic acid Chemical compound FC1=CC(CC[C@@H](N)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 MLIPKGLXHUBXKK-LJQANCHMSA-N 0.000 claims 1
• UOGFSBHCCGELLP-HXUWFJFHSA-N (2r)-3-[2,6-dimethyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenoxy]propane-1,2-diol Chemical compound CC1=C(OC[C@H](O)CO)C(C)=CC(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)=C1 UOGFSBHCCGELLP-HXUWFJFHSA-N 0.000 claims 1
• MRLPAUFHYFKZPJ-LJQANCHMSA-N (2r)-4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]-2-hydroxy-4-oxobutanoic acid Chemical compound FC1=CC(NC(=O)C[C@@H](O)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 MRLPAUFHYFKZPJ-LJQANCHMSA-N 0.000 claims 1
• GXOKDJQBRJNTEG-LJQANCHMSA-N (2r)-4-amino-2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]-4-oxobutanoic acid Chemical compound FC1=CC(N[C@H](CC(=O)N)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 GXOKDJQBRJNTEG-LJQANCHMSA-N 0.000 claims 1
• MQWWGSOFGNLKML-HRAATJIYSA-N (2r,4r)-4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]pyrrolidine-2-carboxylic acid Chemical compound C1N[C@@H](C(=O)O)C[C@@H]1C(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 MQWWGSOFGNLKML-HRAATJIYSA-N 0.000 claims 1
• ICAUQGOTJWRMLA-NRFANRHFSA-N (2s)-1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ICAUQGOTJWRMLA-NRFANRHFSA-N 0.000 claims 1
• LGXUOJNGDSKUJR-QFIPXVFZSA-N (2s)-1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 LGXUOJNGDSKUJR-QFIPXVFZSA-N 0.000 claims 1
• GRHYDNFYDMAIFI-HNNXBMFYSA-N (2s)-2-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methylamino]propanoic acid Chemical compound FC1=CC(CN[C@@H](C)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 GRHYDNFYDMAIFI-HNNXBMFYSA-N 0.000 claims 1
• KMCSQCGFOWMHTE-SFHVURJKSA-N (2s)-2-amino-3-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]propanoic acid Chemical compound FC1=CC(C[C@H](N)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 KMCSQCGFOWMHTE-SFHVURJKSA-N 0.000 claims 1
• VTWSHDBNPHFDGO-VWLOTQADSA-N (2s)-2-amino-4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]-2-methylbutanoic acid Chemical compound FC1=CC(CC[C@@](N)(C)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 VTWSHDBNPHFDGO-VWLOTQADSA-N 0.000 claims 1
• MLIPKGLXHUBXKK-IBGZPJMESA-N (2s)-2-amino-4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]butanoic acid Chemical compound FC1=CC(CC[C@H](N)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 MLIPKGLXHUBXKK-IBGZPJMESA-N 0.000 claims 1
• UOGFSBHCCGELLP-FQEVSTJZSA-N (2s)-3-[2,6-dimethyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenoxy]propane-1,2-diol Chemical compound CC1=C(OC[C@@H](O)CO)C(C)=CC(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)=C1 UOGFSBHCCGELLP-FQEVSTJZSA-N 0.000 claims 1
• MRLPAUFHYFKZPJ-IBGZPJMESA-N (2s)-4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]-2-hydroxy-4-oxobutanoic acid Chemical compound FC1=CC(NC(=O)C[C@H](O)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 MRLPAUFHYFKZPJ-IBGZPJMESA-N 0.000 claims 1
• DCWJFNAOUTVMRH-JTSKRJEESA-N (2s,4r)-4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]-1-methylpyrrolidine-2-carboxylic acid Chemical compound C1[C@@H](C(O)=O)N(C)C[C@H]1C(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 DCWJFNAOUTVMRH-JTSKRJEESA-N 0.000 claims 1
• WTALFFUKIPKJQW-FNZWTVRRSA-N (2s,4r)-4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]-4-hydroxypyrrolidine-2-carboxylic acid Chemical compound C1N[C@H](C(=O)O)C[C@@]1(O)C(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 WTALFFUKIPKJQW-FNZWTVRRSA-N 0.000 claims 1
• OZWBUQJQIFWHIH-CTNGQTDRSA-N (2s,4r)-4-[4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenoxy]pyrrolidine-2-carboxylic acid Chemical compound C1N[C@H](C(=O)O)C[C@H]1OC1=CC=C(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)C=C1 OZWBUQJQIFWHIH-CTNGQTDRSA-N 0.000 claims 1
• AHKKYONYGWYRAR-GOSISDBHSA-N (3r)-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzoyl]piperidine-3-carboxylic acid Chemical compound C1[C@H](C(=O)O)CCCN1C(=O)C(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 AHKKYONYGWYRAR-GOSISDBHSA-N 0.000 claims 1
• DFKVJJCSINDUMY-GOSISDBHSA-N (3r)-1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]pyrrolidine-3-carboxylic acid Chemical compound C1[C@H](C(=O)O)CCN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 DFKVJJCSINDUMY-GOSISDBHSA-N 0.000 claims 1
• ZQJUTZAZNIRVCT-MRXNPFEDSA-N (3r)-3-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methylamino]butanoic acid Chemical compound FC1=CC(CN[C@@H](CC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ZQJUTZAZNIRVCT-MRXNPFEDSA-N 0.000 claims 1
• IOBHKOYYARRWQM-LJQANCHMSA-N (3r)-4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]-3-hydroxy-4-oxobutanoic acid Chemical compound FC1=CC(NC(=O)[C@@H](CC(O)=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 IOBHKOYYARRWQM-LJQANCHMSA-N 0.000 claims 1
• XQPSZKTXVQXRPT-LJQANCHMSA-N (3r)-4-amino-3-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]-4-oxobutanoic acid Chemical compound FC1=CC(N[C@H](CC(O)=O)C(=O)N)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 XQPSZKTXVQXRPT-LJQANCHMSA-N 0.000 claims 1
• ZQJUTZAZNIRVCT-INIZCTEOSA-N (3s)-3-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methylamino]butanoic acid Chemical compound FC1=CC(CN[C@H](CC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ZQJUTZAZNIRVCT-INIZCTEOSA-N 0.000 claims 1
• IOBHKOYYARRWQM-IBGZPJMESA-N (3s)-4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]-3-hydroxy-4-oxobutanoic acid Chemical compound FC1=CC(NC(=O)[C@H](CC(O)=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 IOBHKOYYARRWQM-IBGZPJMESA-N 0.000 claims 1
• ICEIWTRKSBHUPU-MRXNPFEDSA-N 1-[(1r)-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethyl]azetidine-3-carboxylic acid Chemical compound N1([C@H](C)C=2C=C(F)C(C=3SC4=NC(=CC=C4N=3)C3(CC3)C=3C=CC=CC=3)=CC=2)CC(C(O)=O)C1 ICEIWTRKSBHUPU-MRXNPFEDSA-N 0.000 claims 1
• ICEIWTRKSBHUPU-INIZCTEOSA-N 1-[(1s)-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethyl]azetidine-3-carboxylic acid Chemical compound N1([C@@H](C)C=2C=C(F)C(C=3SC4=NC(=CC=C4N=3)C3(CC3)C=3C=CC=CC=3)=CC=2)CC(C(O)=O)C1 ICEIWTRKSBHUPU-INIZCTEOSA-N 0.000 claims 1
• QFDOYUSEQNYASA-UHFFFAOYSA-N 1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]-n-methylcyclopropan-1-amine Chemical compound C=1C=C(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)C(F)=CC=1C1(NC)CC1 QFDOYUSEQNYASA-UHFFFAOYSA-N 0.000 claims 1
• JJMNOHMYOCDTNE-UHFFFAOYSA-N 1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanol Chemical compound FC1=CC(C(O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 JJMNOHMYOCDTNE-UHFFFAOYSA-N 0.000 claims 1
• HZXGZVRQQFGNFN-UHFFFAOYSA-N 1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]pyrrolidin-2-one Chemical compound FC1=CC(N2C(CCC2)=O)=CC=C1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 HZXGZVRQQFGNFN-UHFFFAOYSA-N 0.000 claims 1
• DGRKENUAODQPTI-UHFFFAOYSA-N 1-[[3-amino-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C=1C=C(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)C(N)=CC=1CN1CC(C(O)=O)C1 DGRKENUAODQPTI-UHFFFAOYSA-N 0.000 claims 1
• SQPRETQQWKXEPW-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 SQPRETQQWKXEPW-UHFFFAOYSA-N 0.000 claims 1
• FQXZWIMLHPSJLU-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]pyrazole-3-carboxylic acid Chemical compound N1=C(C(=O)O)C=CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 FQXZWIMLHPSJLU-UHFFFAOYSA-N 0.000 claims 1
• UWFKJTCRWCNSNI-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]pyrazole-4-carboxylic acid Chemical compound C1=C(C(=O)O)C=NN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 UWFKJTCRWCNSNI-UHFFFAOYSA-N 0.000 claims 1
• KBVMVPHQZLQHLY-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methylamino]cyclopropane-1-carboxylic acid Chemical compound C=1C=C(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)C(F)=CC=1CNC1(C(=O)O)CC1 KBVMVPHQZLQHLY-UHFFFAOYSA-N 0.000 claims 1
• RWWBUTGMPHDFGX-UHFFFAOYSA-N 1-[[3-fluoro-4-[6-(1-phenylcyclopropyl)-1,3-benzothiazol-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)C=C2S1 RWWBUTGMPHDFGX-UHFFFAOYSA-N 0.000 claims 1
• QILOXDHVYSGPRP-UHFFFAOYSA-N 1-[[3-fluoro-4-[6-(1-phenylcyclopropyl)-[1,3]thiazolo[4,5-c]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CN=C(C3(CC3)C=3C=CC=CC=3)C=C2S1 QILOXDHVYSGPRP-UHFFFAOYSA-N 0.000 claims 1
• YAEJSOIIAJFYAA-UHFFFAOYSA-N 1-[[3-fluoro-4-[6-(1-pyridin-2-ylcyclopropyl)-1,3-benzothiazol-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3N=CC=CC=3)C=C2S1 YAEJSOIIAJFYAA-UHFFFAOYSA-N 0.000 claims 1
• XYKIBXCLJSGSTN-UHFFFAOYSA-N 1-[[4-[5-(1-cyclobutylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]-3-fluorophenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C3CCC3)N=C2S1 XYKIBXCLJSGSTN-UHFFFAOYSA-N 0.000 claims 1
• NPBBLNMDGIUANQ-UHFFFAOYSA-N 1-[[4-[5-(1-cyclohexylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]-3-fluorophenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C3CCCCC3)N=C2S1 NPBBLNMDGIUANQ-UHFFFAOYSA-N 0.000 claims 1
• ADZPKNJWYUCPPK-UHFFFAOYSA-N 1-[[4-[5-(1-cyclopentylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]-3-fluorophenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C3CCCC3)N=C2S1 ADZPKNJWYUCPPK-UHFFFAOYSA-N 0.000 claims 1
• RLARDFHOEZWBLI-UHFFFAOYSA-N 1-[[4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC1=CC=C(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)C=C1 RLARDFHOEZWBLI-UHFFFAOYSA-N 0.000 claims 1
• NJDMSHLMXQGQPH-UHFFFAOYSA-N 1-[[4-[5-[1-(3,3-difluorocyclobutyl)cyclopropyl]-[1,3]thiazolo[5,4-b]pyridin-2-yl]-3-fluorophenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C3CC(F)(F)C3)N=C2S1 NJDMSHLMXQGQPH-UHFFFAOYSA-N 0.000 claims 1
• WNJZDTVKMZYSDS-UHFFFAOYSA-N 1-[[4-[5-[1-(4,4-difluorocyclohexyl)cyclopropyl]-[1,3]thiazolo[5,4-b]pyridin-2-yl]-3-fluorophenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C3CCC(F)(F)CC3)N=C2S1 WNJZDTVKMZYSDS-UHFFFAOYSA-N 0.000 claims 1
• SINCOKVLJHSFIM-MRXNPFEDSA-N 1-[[4-[5-[1-[(1r)-3,3-difluorocyclopentyl]cyclopropyl]-[1,3]thiazolo[5,4-b]pyridin-2-yl]-3-fluorophenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)[C@H]3CC(F)(F)CC3)N=C2S1 SINCOKVLJHSFIM-MRXNPFEDSA-N 0.000 claims 1
• SINCOKVLJHSFIM-INIZCTEOSA-N 1-[[4-[5-[1-[(1s)-3,3-difluorocyclopentyl]cyclopropyl]-[1,3]thiazolo[5,4-b]pyridin-2-yl]-3-fluorophenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)[C@@H]3CC(F)(F)CC3)N=C2S1 SINCOKVLJHSFIM-INIZCTEOSA-N 0.000 claims 1
• NPEGGYUNIKKWRX-UHFFFAOYSA-N 2,2,2-trifluoro-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanamine Chemical compound FC1=CC(C(N)C(F)(F)F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 NPEGGYUNIKKWRX-UHFFFAOYSA-N 0.000 claims 1
• HMZVKDYDGFUGHL-UHFFFAOYSA-N 2,2,2-trifluoro-n-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]acetamide Chemical compound FC1=CC(NC(=O)C(F)(F)F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 HMZVKDYDGFUGHL-UHFFFAOYSA-N 0.000 claims 1
• DCTBWKCMHAXEPQ-UHFFFAOYSA-N 2-(1h-indol-5-yl)-5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound C1CC1(C=1N=C2SC(=NC2=CC=1)C=1C=C2C=CNC2=CC=1)C1=CC=CC=C1 DCTBWKCMHAXEPQ-UHFFFAOYSA-N 0.000 claims 1
• GTTMJUHHNGKUHO-UHFFFAOYSA-N 2-[1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidin-3-yl]acetic acid Chemical compound C1C(CC(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 GTTMJUHHNGKUHO-UHFFFAOYSA-N 0.000 claims 1
• ZZJXFUOCCZJZIB-UHFFFAOYSA-N 2-[2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethylamino]-2-oxoacetic acid Chemical compound FC1=CC(CCNC(=O)C(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ZZJXFUOCCZJZIB-UHFFFAOYSA-N 0.000 claims 1
• VORCSLWLKKFQHC-UHFFFAOYSA-N 2-[2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethylamino]acetic acid Chemical compound FC1=CC(CCNCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 VORCSLWLKKFQHC-UHFFFAOYSA-N 0.000 claims 1
• SXWDUKRKCWUMIC-UHFFFAOYSA-N 2-[2-fluoro-4-[(3-fluoroazetidin-1-yl)methyl]phenyl]-5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound C1C(F)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 SXWDUKRKCWUMIC-UHFFFAOYSA-N 0.000 claims 1
• CAEJYNFXMQCXEC-UHFFFAOYSA-N 2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]-n,n-dimethylethanamine Chemical compound FC1=CC(CCN(C)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 CAEJYNFXMQCXEC-UHFFFAOYSA-N 0.000 claims 1
• ZDARLJLQSUPMHM-UHFFFAOYSA-N 2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanamine Chemical compound FC1=CC(CCN)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ZDARLJLQSUPMHM-UHFFFAOYSA-N 0.000 claims 1
• AJPDBWBLDLBHFP-UHFFFAOYSA-N 2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanol Chemical compound FC1=CC(CCO)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 AJPDBWBLDLBHFP-UHFFFAOYSA-N 0.000 claims 1
• HIVYIHLBVHGTEB-UHFFFAOYSA-N 2-[4-(azetidin-1-ylmethyl)-2-fluorophenyl]-5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound C=1C=C(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)C(F)=CC=1CN1CCC1 HIVYIHLBVHGTEB-UHFFFAOYSA-N 0.000 claims 1
• SMRWUURWIUGKDT-UHFFFAOYSA-N 2-[4-(azetidin-1-ylmethyl)-3,5-dimethylphenyl]-5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound CC1=CC(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)=CC(C)=C1CN1CCC1 SMRWUURWIUGKDT-UHFFFAOYSA-N 0.000 claims 1
• YEPAMKWOYZLGNG-UHFFFAOYSA-N 2-[5-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]-1,3-dihydroisoindol-2-yl]acetic acid Chemical compound C1=C2CN(CC(=O)O)CC2=CC=C1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 YEPAMKWOYZLGNG-UHFFFAOYSA-N 0.000 claims 1
• WBCIJRRSDSFXLA-UHFFFAOYSA-N 2-[5-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]indol-1-yl]acetic acid Chemical compound C=1C=C2N(CC(=O)O)C=CC2=CC=1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 WBCIJRRSDSFXLA-UHFFFAOYSA-N 0.000 claims 1
• YLQKFWVHNGZHGG-UHFFFAOYSA-N 2-[6-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]-3,4-dihydro-1h-isoquinolin-2-yl]acetic acid Chemical compound C=1C=C2CN(CC(=O)O)CCC2=CC=1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 YLQKFWVHNGZHGG-UHFFFAOYSA-N 0.000 claims 1
• RMFNOJPTVRZKER-UHFFFAOYSA-N 2-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methoxy]acetic acid Chemical compound FC1=CC(COCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 RMFNOJPTVRZKER-UHFFFAOYSA-N 0.000 claims 1
• HUOCVQORDNRUEB-UHFFFAOYSA-N 2-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]pyrazole-3-carboxylic acid Chemical compound OC(=O)C1=CC=NN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 HUOCVQORDNRUEB-UHFFFAOYSA-N 0.000 claims 1
• REZUCMPLONFXFD-UHFFFAOYSA-N 2-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methylamino]-2-methylpropanoic acid Chemical compound FC1=CC(CNC(C)(C)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 REZUCMPLONFXFD-UHFFFAOYSA-N 0.000 claims 1
• VENLOUUVGMBXRA-UHFFFAOYSA-N 2-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methylamino]acetic acid Chemical compound FC1=CC(CNCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 VENLOUUVGMBXRA-UHFFFAOYSA-N 0.000 claims 1
• YUIKHXVWWXKXIN-UHFFFAOYSA-N 2-amino-2-[2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethyl]propane-1,3-diol Chemical compound FC1=CC(CCC(CO)(CO)N)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 YUIKHXVWWXKXIN-UHFFFAOYSA-N 0.000 claims 1
• UFQKEEFNPMAHQH-UHFFFAOYSA-N 2-amino-3-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]propan-1-ol Chemical compound FC1=CC(CC(CO)N)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 UFQKEEFNPMAHQH-UHFFFAOYSA-N 0.000 claims 1
• KMCSQCGFOWMHTE-UHFFFAOYSA-N 2-amino-3-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]propanoic acid Chemical compound FC1=CC(CC(N)C(O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 KMCSQCGFOWMHTE-UHFFFAOYSA-N 0.000 claims 1
• YSSZJWNEWXHKEG-UHFFFAOYSA-N 3-[1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethylamino]butanoic acid Chemical compound FC1=CC(C(C)NC(CC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 YSSZJWNEWXHKEG-UHFFFAOYSA-N 0.000 claims 1
• NMSLMMIQACOIGQ-UHFFFAOYSA-N 3-[1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethylamino]propanoic acid Chemical compound FC1=CC(C(NCCC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 NMSLMMIQACOIGQ-UHFFFAOYSA-N 0.000 claims 1
• OGKHLOKWFGATCA-UHFFFAOYSA-N 3-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]propanoic acid Chemical compound FC1=CC(NCCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 OGKHLOKWFGATCA-UHFFFAOYSA-N 0.000 claims 1
• MLRJRUKHPPYMSX-UHFFFAOYSA-N 3-[3-fluoro-n-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]propanoic acid Chemical compound FC1=CC(N(CCC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 MLRJRUKHPPYMSX-UHFFFAOYSA-N 0.000 claims 1
• JJKYWTRVADBCKT-UHFFFAOYSA-N 3-[4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]propanoic acid Chemical compound C1=CC(NCCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 JJKYWTRVADBCKT-UHFFFAOYSA-N 0.000 claims 1
• KUPNRRBAHXLCPZ-UHFFFAOYSA-N 3-[5-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzimidazol-1-yl]propanoic acid Chemical compound C=1C=C2N(CCC(=O)O)C=NC2=CC=1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 KUPNRRBAHXLCPZ-UHFFFAOYSA-N 0.000 claims 1
• WWFLCFSSZJSBON-UHFFFAOYSA-N 3-[5-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]indol-1-yl]propanoic acid Chemical compound C=1C=C2N(CCC(=O)O)C=CC2=CC=1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 WWFLCFSSZJSBON-UHFFFAOYSA-N 0.000 claims 1
• JPLZHBMBMUPCAN-UHFFFAOYSA-N 3-[6-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]-3,4-dihydro-1h-isoquinolin-2-yl]propanoic acid Chemical compound C=1C=C2CN(CCC(=O)O)CCC2=CC=1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 JPLZHBMBMUPCAN-UHFFFAOYSA-N 0.000 claims 1
• BOUVVZYZJSJQLM-UHFFFAOYSA-N 3-[6-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzimidazol-1-yl]propanoic acid Chemical compound C1=C2N(CCC(=O)O)C=NC2=CC=C1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 BOUVVZYZJSJQLM-UHFFFAOYSA-N 0.000 claims 1
• NMSLMMIQACOIGQ-MRXNPFEDSA-N 3-[[(1r)-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethyl]amino]propanoic acid Chemical compound FC1=CC([C@H](NCCC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 NMSLMMIQACOIGQ-MRXNPFEDSA-N 0.000 claims 1
• NMSLMMIQACOIGQ-INIZCTEOSA-N 3-[[(1s)-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethyl]amino]propanoic acid Chemical compound FC1=CC([C@@H](NCCC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 NMSLMMIQACOIGQ-INIZCTEOSA-N 0.000 claims 1
• OOBALZZYTSAKCV-UHFFFAOYSA-N 3-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzoyl]-methylamino]propanoic acid Chemical compound FC1=CC(C(=O)N(CCC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 OOBALZZYTSAKCV-UHFFFAOYSA-N 0.000 claims 1
• POSXCHANUIGYIM-UHFFFAOYSA-N 3-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzoyl]amino]-3-methylbutanoic acid Chemical compound FC1=CC(C(=O)NC(C)(CC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 POSXCHANUIGYIM-UHFFFAOYSA-N 0.000 claims 1
• NWNPYQKNBUPBID-UHFFFAOYSA-N 3-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzoyl]amino]butanoic acid Chemical compound FC1=CC(C(=O)NC(CC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 NWNPYQKNBUPBID-UHFFFAOYSA-N 0.000 claims 1
• HNVBIOZWSOINAN-UHFFFAOYSA-N 3-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]imidazole-4-carboxylic acid Chemical compound OC(=O)C1=CN=CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 HNVBIOZWSOINAN-UHFFFAOYSA-N 0.000 claims 1
• ZQJUTZAZNIRVCT-UHFFFAOYSA-N 3-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methylamino]butanoic acid Chemical compound FC1=CC(CNC(CC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ZQJUTZAZNIRVCT-UHFFFAOYSA-N 0.000 claims 1
• BJWDQTKPJXMMLJ-UHFFFAOYSA-N 3-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]sulfamoyl]propanoic acid Chemical compound FC1=CC(NS(=O)(=O)CCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 BJWDQTKPJXMMLJ-UHFFFAOYSA-N 0.000 claims 1
• CUZSURWZXLOBBS-UHFFFAOYSA-N 3-fluoro-1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)(F)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 CUZSURWZXLOBBS-UHFFFAOYSA-N 0.000 claims 1
• JILFMCAHUIKLIO-UHFFFAOYSA-N 3-fluoro-n,n-dimethyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]aniline Chemical compound FC1=CC(N(C)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 JILFMCAHUIKLIO-UHFFFAOYSA-N 0.000 claims 1
• BLCXSRMPGZPVSR-UHFFFAOYSA-N 3-fluoro-n-(2-hydroxyethyl)-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzamide Chemical compound FC1=CC(C(=O)NCCO)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 BLCXSRMPGZPVSR-UHFFFAOYSA-N 0.000 claims 1
• IVKZRYKWMWLVFH-UHFFFAOYSA-N 3-fluoro-n-(2-hydroxyethyl)-n-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzamide Chemical compound FC1=CC(C(=O)N(CCO)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 IVKZRYKWMWLVFH-UHFFFAOYSA-N 0.000 claims 1
• FSAIBDFYVQAJND-UHFFFAOYSA-N 3-fluoro-n-(2-methoxyethyl)-n-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzamide Chemical compound FC1=CC(C(=O)N(C)CCOC)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 FSAIBDFYVQAJND-UHFFFAOYSA-N 0.000 claims 1
• QWMWNHLXLLSOKR-UHFFFAOYSA-N 3-fluoro-n-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]aniline Chemical compound FC1=CC(NC)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 QWMWNHLXLLSOKR-UHFFFAOYSA-N 0.000 claims 1
• RNJUDXBXJHLETI-UHFFFAOYSA-N 4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]-4-oxobutanoic acid Chemical compound FC1=CC(NC(=O)CCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 RNJUDXBXJHLETI-UHFFFAOYSA-N 0.000 claims 1
• AKZSHTFFWDWNND-UHFFFAOYSA-N 4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]butanoic acid Chemical compound FC1=CC(NCCCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 AKZSHTFFWDWNND-UHFFFAOYSA-N 0.000 claims 1
• KOPIRZFQEIFTSN-UHFFFAOYSA-N 4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]butanoic acid Chemical compound FC1=CC(CCCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 KOPIRZFQEIFTSN-UHFFFAOYSA-N 0.000 claims 1
• XBKILKNNBQTDCQ-UHFFFAOYSA-N 4-[5-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]indol-1-yl]butanoic acid Chemical compound C=1C=C2N(CCCC(=O)O)C=CC2=CC=1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 XBKILKNNBQTDCQ-UHFFFAOYSA-N 0.000 claims 1
• ADQCMQKHRUBGRF-UHFFFAOYSA-N 4-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methylamino]butanoic acid Chemical compound FC1=CC(CNCCCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ADQCMQKHRUBGRF-UHFFFAOYSA-N 0.000 claims 1
• ITBDZPRPGHDUBJ-UHFFFAOYSA-N 5-(1-phenylcyclopropyl)-2-(1,2,3,4-tetrahydroisoquinolin-6-yl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound C1CC1(C=1N=C2SC(=NC2=CC=1)C=1C=C2CCNCC2=CC=1)C1=CC=CC=C1 ITBDZPRPGHDUBJ-UHFFFAOYSA-N 0.000 claims 1
• QJWAKJAJWGWJSA-MSOLQXFVSA-N CC[C@@H](C)N[C@@H](C)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F Chemical compound CC[C@@H](C)N[C@@H](C)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F QJWAKJAJWGWJSA-MSOLQXFVSA-N 0.000 claims 1
• QJWAKJAJWGWJSA-QZTJIDSGSA-N CC[C@@H](C)N[C@H](C)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F Chemical compound CC[C@@H](C)N[C@H](C)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F QJWAKJAJWGWJSA-QZTJIDSGSA-N 0.000 claims 1
• QJWAKJAJWGWJSA-ROUUACIJSA-N CC[C@H](C)N[C@@H](C)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F Chemical compound CC[C@H](C)N[C@@H](C)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F QJWAKJAJWGWJSA-ROUUACIJSA-N 0.000 claims 1
• QJWAKJAJWGWJSA-ZWKOTPCHSA-N CC[C@H](C)N[C@H](C)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F Chemical compound CC[C@H](C)N[C@H](C)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F QJWAKJAJWGWJSA-ZWKOTPCHSA-N 0.000 claims 1
• IRGIFSXKYPXSBD-UHFFFAOYSA-N [3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]-morpholin-4-ylmethanone Chemical compound FC1=CC(C(=O)N2CCOCC2)=CC=C1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 IRGIFSXKYPXSBD-UHFFFAOYSA-N 0.000 claims 1
• YTAKZXXBIDPOAP-UHFFFAOYSA-N [3-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methanol Chemical compound CC1=CC(CO)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 YTAKZXXBIDPOAP-UHFFFAOYSA-N 0.000 claims 1
• RCTXHEXKKARZFA-UHFFFAOYSA-N [4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methanol Chemical compound C1=CC(CO)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 RCTXHEXKKARZFA-UHFFFAOYSA-N 0.000 claims 1
• 229960001230 asparagine Drugs 0.000 claims 1
• JCCGIKNSLIPCCD-UHFFFAOYSA-N azetidin-1-yl-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methanone Chemical compound FC1=CC(C(=O)N2CCC2)=CC=C1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 JCCGIKNSLIPCCD-UHFFFAOYSA-N 0.000 claims 1
• YODAEFAGFNJTGE-UHFFFAOYSA-N n-[2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethyl]acetamide Chemical compound FC1=CC(CCNC(=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 YODAEFAGFNJTGE-UHFFFAOYSA-N 0.000 claims 1
• PLUIYEKALHTZBV-UHFFFAOYSA-N n-[2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethyl]methanesulfonamide Chemical compound FC1=CC(CCNS(=O)(=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 PLUIYEKALHTZBV-UHFFFAOYSA-N 0.000 claims 1
• UMVZQXCHROWXCM-UHFFFAOYSA-N n-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]-n-methylsulfonylmethanesulfonamide Chemical compound FC1=CC(N(S(=O)(=O)C)S(C)(=O)=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 UMVZQXCHROWXCM-UHFFFAOYSA-N 0.000 claims 1
• RQZHJTNQCQBUTE-UHFFFAOYSA-N n-benzyl-2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanamine Chemical compound C=1C=C(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)C(F)=CC=1CCNCC1=CC=CC=C1 RQZHJTNQCQBUTE-UHFFFAOYSA-N 0.000 claims 1
• HYMNOIMQTZDKMR-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzamide Chemical compound FC1=CC(C(=O)NC2CC2)=CC=C1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 HYMNOIMQTZDKMR-UHFFFAOYSA-N 0.000 claims 1
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 214
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 192
• 239000011541 reaction mixture Substances 0.000 description 186
• 239000007787 solid Substances 0.000 description 172
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 167
• 201000006417 multiple sclerosis Diseases 0.000 description 164
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 152
• 239000000243 solution Substances 0.000 description 145
• 230000002829 reductive effect Effects 0.000 description 131
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 131
• 239000000203 mixture Substances 0.000 description 130
• 239000000460 chlorine Substances 0.000 description 106
• 238000006243 chemical reaction Methods 0.000 description 75
• 239000012044 organic layer Substances 0.000 description 71
• 238000000034 method Methods 0.000 description 70
• 235000019439 ethyl acetate Nutrition 0.000 description 69
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 68
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 67
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 66
• 238000003786 synthesis reaction Methods 0.000 description 65
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 64
• 230000015572 biosynthetic process Effects 0.000 description 60
• IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 59
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 56
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 49
• 229910052938 sodium sulfate Inorganic materials 0.000 description 47
• 235000011152 sodium sulphate Nutrition 0.000 description 47
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 45
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 44
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 44
• 239000012267 brine Substances 0.000 description 44
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 44
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 43
• 239000002002 slurry Substances 0.000 description 42
• 239000000741 silica gel Substances 0.000 description 40
• 229910002027 silica gel Inorganic materials 0.000 description 40
• 239000003814 drug Substances 0.000 description 39
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 37
• 229910052786 argon Inorganic materials 0.000 description 34
• IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 34
• 229910000041 hydrogen chloride Inorganic materials 0.000 description 34
• 239000003921 oil Substances 0.000 description 33
• 235000019198 oils Nutrition 0.000 description 33
• 239000010410 layer Substances 0.000 description 32
• 239000000463 material Substances 0.000 description 32
• 238000010898 silica gel chromatography Methods 0.000 description 32
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 29
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 28
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 27
• 229910052740 iodine Inorganic materials 0.000 description 25
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 24
• 239000000047 product Substances 0.000 description 24
• 238000000746 purification Methods 0.000 description 24
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
• UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 22
• 239000002904 solvent Substances 0.000 description 22
• 238000011282 treatment Methods 0.000 description 22
• 238000010931 ester hydrolysis Methods 0.000 description 21
• 229940124597 therapeutic agent Drugs 0.000 description 21
• 238000009472 formulation Methods 0.000 description 20
• 238000010992 reflux Methods 0.000 description 20
• 235000002639 sodium chloride Nutrition 0.000 description 19
• 230000000694 effects Effects 0.000 description 18
• 239000000725 suspension Substances 0.000 description 18
• 239000000706 filtrate Substances 0.000 description 17
• 150000002430 hydrocarbons Chemical group 0.000 description 17
• 238000006268 reductive amination reaction Methods 0.000 description 17
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 16
• 239000007864 aqueous solution Substances 0.000 description 16
• 125000004432 carbon atom Chemical group C* 0.000 description 16
• 229940079593 drug Drugs 0.000 description 16
• NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 16
• BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 15
• 229960000583 acetic acid Drugs 0.000 description 14
• 239000000284 extract Substances 0.000 description 14
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 14
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 14
• GIHSRFKFTOSKQX-UHFFFAOYSA-N 3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzaldehyde Chemical compound FC1=CC(C=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 GIHSRFKFTOSKQX-UHFFFAOYSA-N 0.000 description 13
• 235000011054 acetic acid Nutrition 0.000 description 13
• 150000001412 amines Chemical class 0.000 description 13
• 238000006460 hydrolysis reaction Methods 0.000 description 13
• 239000002244 precipitate Substances 0.000 description 13
• 125000006413 ring segment Chemical group 0.000 description 13
• 239000004480 active ingredient Substances 0.000 description 12
• JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 12
• 238000001914 filtration Methods 0.000 description 12
• 230000007062 hydrolysis Effects 0.000 description 12
• 229910000029 sodium carbonate Inorganic materials 0.000 description 12
• 229940001593 sodium carbonate Drugs 0.000 description 12
• MWTKSCLVHADHHR-UHFFFAOYSA-N 5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound C1CC1(C=1N=C2SC=NC2=CC=1)C1=CC=CC=C1 MWTKSCLVHADHHR-UHFFFAOYSA-N 0.000 description 11
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
• 229960000556 fingolimod Drugs 0.000 description 11
• SWZTYAVBMYWFGS-UHFFFAOYSA-N fingolimod hydrochloride Chemical compound Cl.CCCCCCCCC1=CC=C(CCC(N)(CO)CO)C=C1 SWZTYAVBMYWFGS-UHFFFAOYSA-N 0.000 description 11
• 239000006260 foam Substances 0.000 description 11
• 238000004007 reversed phase HPLC Methods 0.000 description 11
• 239000011734 sodium Substances 0.000 description 11
• 235000017557 sodium bicarbonate Nutrition 0.000 description 11
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 11
• BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 11
• 238000003756 stirring Methods 0.000 description 11
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 10
• 239000002585 base Substances 0.000 description 10
• 239000002775 capsule Substances 0.000 description 10
• 239000007788 liquid Substances 0.000 description 10
• 239000003960 organic solvent Substances 0.000 description 10
• LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 10
• 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 10
• 102000005962 receptors Human genes 0.000 description 10
• 108020003175 receptors Proteins 0.000 description 10
• DUYSYHSSBDVJSM-KRWOKUGFSA-N sphingosine 1-phosphate Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP(O)(O)=O DUYSYHSSBDVJSM-KRWOKUGFSA-N 0.000 description 10
• MSHKVNVFZSXCBP-UHFFFAOYSA-N CCl.N1CC(C1)C(=O)O Chemical compound CCl.N1CC(C1)C(=O)O MSHKVNVFZSXCBP-UHFFFAOYSA-N 0.000 description 9
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
• 239000000556 agonist Substances 0.000 description 9
• 235000019441 ethanol Nutrition 0.000 description 9
• 125000005843 halogen group Chemical group 0.000 description 9
• 239000003826 tablet Substances 0.000 description 9
• 210000001519 tissue Anatomy 0.000 description 9
• BPLKQGGAXWRFOE-UHFFFAOYSA-M trimethylsulfoxonium iodide Chemical compound [I-].C[S+](C)(C)=O BPLKQGGAXWRFOE-UHFFFAOYSA-M 0.000 description 9
• YFUSAUGVNWZGAQ-UHFFFAOYSA-N 5-chloro-2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-[1,3]thiazolo[5,4-b]pyridine Chemical compound C=1C=C(C=2SC3=NC(Cl)=CC=C3N=2)C(F)=CC=1C1OCCCO1 YFUSAUGVNWZGAQ-UHFFFAOYSA-N 0.000 description 8
• WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 8
• MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 8
• 238000005481 NMR spectroscopy Methods 0.000 description 8
• HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 8
• 238000011097 chromatography purification Methods 0.000 description 8
• 238000002648 combination therapy Methods 0.000 description 8
• 210000004698 lymphocyte Anatomy 0.000 description 8
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
• 229940002612 prodrug Drugs 0.000 description 8
• 239000000651 prodrug Substances 0.000 description 8
• FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
• QZEFMXVLUXINLH-UHFFFAOYSA-N 3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzoic acid Chemical compound FC1=CC(C(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 QZEFMXVLUXINLH-UHFFFAOYSA-N 0.000 description 7
• 208000023275 Autoimmune disease Diseases 0.000 description 7
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 7
• 210000004027 cell Anatomy 0.000 description 7
• 239000003153 chemical reaction reagent Substances 0.000 description 7
• UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Substances CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 7
• 238000002347 injection Methods 0.000 description 7
• 239000007924 injection Substances 0.000 description 7
• 210000000056 organ Anatomy 0.000 description 7
• 230000001225 therapeutic effect Effects 0.000 description 7
• LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 6
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
• 102100025750 Sphingosine 1-phosphate receptor 1 Human genes 0.000 description 6
• DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 6
• 229910000024 caesium carbonate Inorganic materials 0.000 description 6
• XJHCXCQVJFPJIK-UHFFFAOYSA-M caesium fluoride Chemical compound [F-].[Cs+] XJHCXCQVJFPJIK-UHFFFAOYSA-M 0.000 description 6
• 238000004587 chromatography analysis Methods 0.000 description 6
• NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 6
• CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 6
• 239000002552 dosage form Substances 0.000 description 6
• 150000002148 esters Chemical class 0.000 description 6
• FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 6
• 239000003446 ligand Substances 0.000 description 6
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 6
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
• 239000002609 medium Substances 0.000 description 6
• KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
• 239000000546 pharmaceutical excipient Substances 0.000 description 6
• 239000006187 pill Substances 0.000 description 6
• 239000000843 powder Substances 0.000 description 6
• YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 6
• 229940095064 tartrate Drugs 0.000 description 6
• 238000005160 1H NMR spectroscopy Methods 0.000 description 5
• DWOZNANUEDYIOF-UHFFFAOYSA-L 4-ditert-butylphosphanyl-n,n-dimethylaniline;dichloropalladium Chemical compound Cl[Pd]Cl.CN(C)C1=CC=C(P(C(C)(C)C)C(C)(C)C)C=C1.CN(C)C1=CC=C(P(C(C)(C)C)C(C)(C)C)C=C1 DWOZNANUEDYIOF-UHFFFAOYSA-L 0.000 description 5
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 5
• 108091006027 G proteins Proteins 0.000 description 5
• 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 5
• 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 5
• 102000030782 GTP binding Human genes 0.000 description 5
• 108091000058 GTP-Binding Proteins 0.000 description 5
• 101710155454 Sphingosine 1-phosphate receptor 1 Proteins 0.000 description 5
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 5
• 230000004913 activation Effects 0.000 description 5
• 125000004390 alkyl sulfonyl group Chemical group 0.000 description 5
• 125000002947 alkylene group Chemical group 0.000 description 5
• 125000003277 amino group Chemical group 0.000 description 5
• 239000003795 chemical substances by application Substances 0.000 description 5
• 208000035475 disorder Diseases 0.000 description 5
• 239000006185 dispersion Substances 0.000 description 5
• 239000000543 intermediate Substances 0.000 description 5
• WGEYNHXHVVYOSK-UHFFFAOYSA-N methyl azetidine-3-carboxylate Chemical compound COC(=O)C1CNC1 WGEYNHXHVVYOSK-UHFFFAOYSA-N 0.000 description 5
• 125000003386 piperidinyl group Chemical group 0.000 description 5
• 238000002360 preparation method Methods 0.000 description 5
• JAEIBKXSIXOLOL-UHFFFAOYSA-N pyrrolidin-1-ium-3-carboxylate Chemical compound OC(=O)C1CCNC1 JAEIBKXSIXOLOL-UHFFFAOYSA-N 0.000 description 5
• 238000000926 separation method Methods 0.000 description 5
• FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 5
• 238000003828 vacuum filtration Methods 0.000 description 5
• WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
• BRKZFIMCMKWYOL-UHFFFAOYSA-N 1-[[2,6-dimethyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid Chemical compound CC1=CC(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)=CC(C)=C1CN1CC(C(O)=O)C1 BRKZFIMCMKWYOL-UHFFFAOYSA-N 0.000 description 4
• WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 description 4
• YJCPVMYUISTDKG-UHFFFAOYSA-N 1-phenylethenylboronic acid Chemical compound OB(O)C(=C)C1=CC=CC=C1 YJCPVMYUISTDKG-UHFFFAOYSA-N 0.000 description 4
• USJYOWPOWKXROR-UHFFFAOYSA-N 2,6-dichloro-3-isothiocyanatopyridine Chemical compound ClC1=CC=C(N=C=S)C(Cl)=N1 USJYOWPOWKXROR-UHFFFAOYSA-N 0.000 description 4
• JGKJWBWPTVSYKS-UHFFFAOYSA-N 2-(4-bromo-3-fluorophenyl)-1,3-dioxane Chemical compound C1=C(Br)C(F)=CC(C2OCCCO2)=C1 JGKJWBWPTVSYKS-UHFFFAOYSA-N 0.000 description 4
• VGYIUKIGKVFBIK-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-(1-phenylethenyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2C(=C)C1=CC=CC=C1 VGYIUKIGKVFBIK-UHFFFAOYSA-N 0.000 description 4
• PCACWFHOXMWEJP-UHFFFAOYSA-N 2-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzaldehyde Chemical compound C1=C(C=O)C(C)=CC(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)=C1 PCACWFHOXMWEJP-UHFFFAOYSA-N 0.000 description 4
• BKOOMYPCSUNDGP-UHFFFAOYSA-N 2-methylbut-2-ene Chemical compound CC=C(C)C BKOOMYPCSUNDGP-UHFFFAOYSA-N 0.000 description 4
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
• 206010009900 Colitis ulcerative Diseases 0.000 description 4
• 208000011231 Crohn disease Diseases 0.000 description 4
• 108010010803 Gelatin Proteins 0.000 description 4
• BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 4
• SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
• 201000004681 Psoriasis Diseases 0.000 description 4
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
• 206010052779 Transplant rejections Diseases 0.000 description 4
• 201000006704 Ulcerative Colitis Diseases 0.000 description 4
• 230000002378 acidificating effect Effects 0.000 description 4
• 239000013543 active substance Substances 0.000 description 4
• 230000001154 acute effect Effects 0.000 description 4
• AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 4
• 238000010640 amide synthesis reaction Methods 0.000 description 4
• 239000007900 aqueous suspension Substances 0.000 description 4
• 125000003710 aryl alkyl group Chemical group 0.000 description 4
• RNIZUCJGSDJAOQ-UHFFFAOYSA-N azetidine-3-carboxylic acid;hydrochloride Chemical compound Cl.OC(=O)C1CNC1 RNIZUCJGSDJAOQ-UHFFFAOYSA-N 0.000 description 4
• 230000009286 beneficial effect Effects 0.000 description 4
• 230000036755 cellular response Effects 0.000 description 4
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 4
• 238000000576 coating method Methods 0.000 description 4
• 238000004440 column chromatography Methods 0.000 description 4
• 239000013078 crystal Substances 0.000 description 4
• 125000004122 cyclic group Chemical group 0.000 description 4
• WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 description 4
• 239000002612 dispersion medium Substances 0.000 description 4
• 239000003480 eluent Substances 0.000 description 4
• 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 4
• 239000008273 gelatin Substances 0.000 description 4
• 229920000159 gelatin Polymers 0.000 description 4
• 229940014259 gelatin Drugs 0.000 description 4
• 235000019322 gelatine Nutrition 0.000 description 4
• 235000011852 gelatine desserts Nutrition 0.000 description 4
• 239000011521 glass Substances 0.000 description 4
• 235000011187 glycerol Nutrition 0.000 description 4
• 125000005842 heteroatom Chemical group 0.000 description 4
• 150000003840 hydrochlorides Chemical class 0.000 description 4
• 230000028993 immune response Effects 0.000 description 4
• 210000000987 immune system Anatomy 0.000 description 4
• 239000004615 ingredient Substances 0.000 description 4
• 238000001990 intravenous administration Methods 0.000 description 4
• 239000007951 isotonicity adjuster Substances 0.000 description 4
• 238000004519 manufacturing process Methods 0.000 description 4
• BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
• SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 4
• CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
• QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 4
• 239000008363 phosphate buffer Substances 0.000 description 4
• 229910000027 potassium carbonate Inorganic materials 0.000 description 4
• 235000011181 potassium carbonates Nutrition 0.000 description 4
• 230000002265 prevention Effects 0.000 description 4
• 230000002441 reversible effect Effects 0.000 description 4
• 206010039073 rheumatoid arthritis Diseases 0.000 description 4
• 239000011780 sodium chloride Substances 0.000 description 4
• 229910000104 sodium hydride Inorganic materials 0.000 description 4
• GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
• ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 4
• UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 4
• RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
• FNQJDLTXOVEEFB-UHFFFAOYSA-N 1,2,3-benzothiadiazole Chemical compound C1=CC=C2SN=NC2=C1 FNQJDLTXOVEEFB-UHFFFAOYSA-N 0.000 description 3
• QXAMRNAGVOMCKP-UHFFFAOYSA-N 1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanone Chemical compound FC1=CC(C(=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 QXAMRNAGVOMCKP-UHFFFAOYSA-N 0.000 description 3
• BAQTZEBJKINDGJ-UHFFFAOYSA-N 1-[[4-(5-benzoyl-[1,3]thiazolo[5,4-b]pyridin-2-yl)-3-fluorophenyl]methyl]azetidine-3-carboxylic acid Chemical compound C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C(=O)C=3C=CC=CC=3)N=C2S1 BAQTZEBJKINDGJ-UHFFFAOYSA-N 0.000 description 3
• BPAHOSKWYPCLMJ-UHFFFAOYSA-N 2,6-dimethyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzaldehyde Chemical compound CC1=C(C=O)C(C)=CC(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)=C1 BPAHOSKWYPCLMJ-UHFFFAOYSA-N 0.000 description 3
• WEFAUVJQWYQPRL-UHFFFAOYSA-N 2-(4-bromo-2,6-dimethylphenyl)-1,3-dioxane Chemical compound CC1=CC(Br)=CC(C)=C1C1OCCCO1 WEFAUVJQWYQPRL-UHFFFAOYSA-N 0.000 description 3
• DTMWRLDCZPNMIM-UHFFFAOYSA-N 2-(4-ethenyl-2-fluorophenyl)-5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C=C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 DTMWRLDCZPNMIM-UHFFFAOYSA-N 0.000 description 3
• VUPDFVIJDNSHCE-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-3,5-dimethylphenyl]-5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound CC1=CC(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)=CC(C)=C1C1OCCCO1 VUPDFVIJDNSHCE-UHFFFAOYSA-N 0.000 description 3
• GCPTZBNRKKOGBF-UHFFFAOYSA-N 2-amino-2-[2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethyl]propane-1,3-diol;hydrochloride Chemical compound Cl.FC1=CC(CCC(CO)(CO)N)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 GCPTZBNRKKOGBF-UHFFFAOYSA-N 0.000 description 3
• ARBPOOGJUBHZKF-UHFFFAOYSA-N 2-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzonitrile Chemical compound C1=C(C#N)C(C)=CC(C=2SC3=NC(=CC=C3N=2)C2(CC2)C=2C=CC=CC=2)=C1 ARBPOOGJUBHZKF-UHFFFAOYSA-N 0.000 description 3
• QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 description 3
• GFJXYZNIXOXTIB-UHFFFAOYSA-N 3-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzaldehyde Chemical compound CC1=CC(C=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 GFJXYZNIXOXTIB-UHFFFAOYSA-N 0.000 description 3
• ZZAZLSIUKDXEKL-UHFFFAOYSA-N 3-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzonitrile Chemical compound CC1=CC(C#N)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ZZAZLSIUKDXEKL-UHFFFAOYSA-N 0.000 description 3
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• 229910021595 Copper(I) iodide Inorganic materials 0.000 description 3
• 229920002261 Corn starch Polymers 0.000 description 3
• QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
• 206010016654 Fibrosis Diseases 0.000 description 3
• WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
• 239000007821 HATU Substances 0.000 description 3
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• 206010028980 Neoplasm Diseases 0.000 description 3
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
• 101150003085 Pdcl gene Proteins 0.000 description 3
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
• KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
• VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• 238000010521 absorption reaction Methods 0.000 description 3
• 230000009471 action Effects 0.000 description 3
• 125000004183 alkoxy alkyl group Chemical group 0.000 description 3
• 125000003545 alkoxy group Chemical group 0.000 description 3
• 125000004448 alkyl carbonyl group Chemical group 0.000 description 3
• HFEHLDPGIKPNKL-UHFFFAOYSA-N allyl iodide Chemical compound ICC=C HFEHLDPGIKPNKL-UHFFFAOYSA-N 0.000 description 3
• PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
• 239000005557 antagonist Substances 0.000 description 3
• 239000003429 antifungal agent Substances 0.000 description 3
• 229940121375 antifungal agent Drugs 0.000 description 3
• 238000006254 arylation reaction Methods 0.000 description 3
• 239000012298 atmosphere Substances 0.000 description 3
• 230000001363 autoimmune Effects 0.000 description 3
• VEVJTUNLALKRNO-TYHXJLICSA-N benzoyl-CoA Chemical compound O=C([C@H](O)C(C)(COP(O)(=O)OP(O)(=O)OC[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C2=NC=NC(N)=C2N=C1)OP(O)(O)=O)C)NCCC(=O)NCCSC(=O)C1=CC=CC=C1 VEVJTUNLALKRNO-TYHXJLICSA-N 0.000 description 3
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
• 229910052794 bromium Inorganic materials 0.000 description 3
• 201000011510 cancer Diseases 0.000 description 3
• 239000000969 carrier Substances 0.000 description 3
• 230000001684 chronic effect Effects 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 239000011248 coating agent Substances 0.000 description 3
• 239000008120 corn starch Substances 0.000 description 3
• 239000013058 crude material Substances 0.000 description 3
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 3
• 239000003937 drug carrier Substances 0.000 description 3
• RJCGNNHKSNIUAT-UHFFFAOYSA-N ethyl 3-aminopropanoate;hydron;chloride Chemical compound Cl.CCOC(=O)CCN RJCGNNHKSNIUAT-UHFFFAOYSA-N 0.000 description 3
• 239000013022 formulation composition Substances 0.000 description 3
• 125000002541 furyl group Chemical group 0.000 description 3
• 150000004820 halides Chemical class 0.000 description 3
• 208000006454 hepatitis Diseases 0.000 description 3
• 231100000283 hepatitis Toxicity 0.000 description 3
• 238000001727 in vivo Methods 0.000 description 3
• 208000027866 inflammatory disease Diseases 0.000 description 3
• FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 3
• 235000019359 magnesium stearate Nutrition 0.000 description 3
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
• 235000019341 magnesium sulphate Nutrition 0.000 description 3
• CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 3
• UOCWTLBPYROHEF-UHFFFAOYSA-N methyl azetidine-3-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1CNC1 UOCWTLBPYROHEF-UHFFFAOYSA-N 0.000 description 3
• 244000005700 microbiome Species 0.000 description 3
• 230000000269 nucleophilic effect Effects 0.000 description 3
• 229920001223 polyethylene glycol Polymers 0.000 description 3
• 238000002953 preparative HPLC Methods 0.000 description 3
• 239000003755 preservative agent Substances 0.000 description 3
• 235000013772 propylene glycol Nutrition 0.000 description 3
• 229960004063 propylene glycol Drugs 0.000 description 3
• 125000004076 pyridyl group Chemical group 0.000 description 3
• 125000000714 pyrimidinyl group Chemical group 0.000 description 3
• 125000000168 pyrrolyl group Chemical group 0.000 description 3
• 150000003254 radicals Chemical class 0.000 description 3
• 239000002994 raw material Substances 0.000 description 3
• 229910052708 sodium Inorganic materials 0.000 description 3
• 239000001632 sodium acetate Substances 0.000 description 3
• 235000017281 sodium acetate Nutrition 0.000 description 3
• 239000012312 sodium hydride Substances 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 239000000829 suppository Substances 0.000 description 3
• 238000013268 sustained release Methods 0.000 description 3
• 239000012730 sustained-release form Substances 0.000 description 3
• 125000001412 tetrahydropyranyl group Chemical group 0.000 description 3
• 125000001544 thienyl group Chemical group 0.000 description 3
• 125000003944 tolyl group Chemical group 0.000 description 3
• DBGVGMSCBYYSLD-UHFFFAOYSA-N tributylstannane Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 3
• 238000001665 trituration Methods 0.000 description 3
• 229920002554 vinyl polymer Polymers 0.000 description 3
• OHDAURMSEHMPFJ-LJQANCHMSA-N (1r)-2,2,2-trifluoro-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanol Chemical compound FC1=CC([C@@H](O)C(F)(F)F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 OHDAURMSEHMPFJ-LJQANCHMSA-N 0.000 description 2
• QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 description 2
• IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 2
• JEZSFBRAIYOTAG-UHFFFAOYSA-N 1-(2-fluorophenyl)ethenyl trifluoromethanesulfonate Chemical compound FC1=CC=CC=C1C(=C)OS(=O)(=O)C(F)(F)F JEZSFBRAIYOTAG-UHFFFAOYSA-N 0.000 description 2
• LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
• ZKHKNVVKHAJPPV-UHFFFAOYSA-N 1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]propan-1-ol Chemical compound FC1=CC(C(O)CC)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ZKHKNVVKHAJPPV-UHFFFAOYSA-N 0.000 description 2
• CXDQMOKZENRNDR-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[4,5-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=NC(C3(CC3)C=3C=CC=CC=3)=CC=C2S1 CXDQMOKZENRNDR-UHFFFAOYSA-N 0.000 description 2
• LEDLKEWBFGRIEQ-UHFFFAOYSA-N 1-benzhydryl-3-(4-methylphenyl)sulfonylazetidine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C1CN(C(C=2C=CC=CC=2)C=2C=CC=CC=2)C1 LEDLKEWBFGRIEQ-UHFFFAOYSA-N 0.000 description 2
• 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 description 2
• KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Chemical compound C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 2
• FZWBNHMXJMCXLU-UHFFFAOYSA-N 2,3,4,5-tetrahydroxy-6-[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexanal Chemical compound OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC(O)C(O)C(O)C(O)C=O)O1 FZWBNHMXJMCXLU-UHFFFAOYSA-N 0.000 description 2
• YQNBSOCHHZSSPR-UHFFFAOYSA-N 2,4-dichloro-5-isothiocyanatopyridine Chemical compound ClC1=CC(Cl)=C(N=C=S)C=N1 YQNBSOCHHZSSPR-UHFFFAOYSA-N 0.000 description 2
• MJVZSRZTBDMYLX-UHFFFAOYSA-N 2,6-dichloropyridin-3-amine Chemical compound NC1=CC=C(Cl)N=C1Cl MJVZSRZTBDMYLX-UHFFFAOYSA-N 0.000 description 2
• ZZWHJTJJIBGMMR-UHFFFAOYSA-N 2-(2-fluoro-4-methylphenyl)-5-(1-phenylcyclobutyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C)=CC=C1C1=NC2=CC=C(C3(CCC3)C=3C=CC=CC=3)N=C2S1 ZZWHJTJJIBGMMR-UHFFFAOYSA-N 0.000 description 2
• WNLKAHLIRHVZAQ-UHFFFAOYSA-N 2-(2-fluoro-4-methylphenyl)-5-(1-phenylethenyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C)=CC=C1C1=NC2=CC=C(C(=C)C=3C=CC=CC=3)N=C2S1 WNLKAHLIRHVZAQ-UHFFFAOYSA-N 0.000 description 2
• CSGNZLKPHTZPDM-UHFFFAOYSA-N 2-(azetidin-3-yl)acetic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)CC1CNC1 CSGNZLKPHTZPDM-UHFFFAOYSA-N 0.000 description 2
• VEFHUWJIRFTGRB-UHFFFAOYSA-N 2-[1-[(2-methylpropan-2-yl)oxycarbonyl]azetidin-3-yl]acetic acid Chemical compound CC(C)(C)OC(=O)N1CC(CC(O)=O)C1 VEFHUWJIRFTGRB-UHFFFAOYSA-N 0.000 description 2
• NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
• PCTXIJLGSACTNR-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-(1-phenylbut-3-enyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2C(CC=C)C1=CC=CC=C1 PCTXIJLGSACTNR-UHFFFAOYSA-N 0.000 description 2
• MADSNSZDXYNPLT-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-(1-phenylcyclohexyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CCCCC1 MADSNSZDXYNPLT-UHFFFAOYSA-N 0.000 description 2
• AIFYEBJJTKFUDF-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-(1-phenylcyclopent-3-en-1-yl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC=CC1 AIFYEBJJTKFUDF-UHFFFAOYSA-N 0.000 description 2
• HAVDRWQONRMADR-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 HAVDRWQONRMADR-UHFFFAOYSA-N 0.000 description 2
• VFEQJOPGTNIJCU-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-(1-phenylethenyl)-[1,3]thiazolo[4,5-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=CC=2)=NC1=NC=2C(=C)C1=CC=CC=C1 VFEQJOPGTNIJCU-UHFFFAOYSA-N 0.000 description 2
• ZAVXLRYXHYSAGO-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-(4-phenylhepta-1,6-dien-4-yl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2C(CC=C)(CC=C)C1=CC=CC=C1 ZAVXLRYXHYSAGO-UHFFFAOYSA-N 0.000 description 2
• LWFAYDWPIABMSR-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-(4-phenylocta-1,7-dien-4-yl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2C(CCC=C)(CC=C)C1=CC=CC=C1 LWFAYDWPIABMSR-UHFFFAOYSA-N 0.000 description 2
• MWTQTTORSCCZOQ-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-[1-(4-phenylmethoxyphenyl)cyclopropyl]-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2C1(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)CC1 MWTQTTORSCCZOQ-UHFFFAOYSA-N 0.000 description 2
• PGCZDKMQVIOATE-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-6-(1-phenylcyclopropyl)-1,3-benzothiazole Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=C2)=NC1=CC=C2C1(C=2C=CC=CC=2)CC1 PGCZDKMQVIOATE-UHFFFAOYSA-N 0.000 description 2
• RPWRQUIVIPTQNR-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-6-(1-phenylethenyl)-1,3-benzothiazole Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=C2)=NC1=CC=C2C(=C)C1=CC=CC=C1 RPWRQUIVIPTQNR-UHFFFAOYSA-N 0.000 description 2
• KWKWGWUCFLDNDI-UHFFFAOYSA-N 2-[4-(bromomethyl)-2-fluorophenyl]-5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(CBr)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 KWKWGWUCFLDNDI-UHFFFAOYSA-N 0.000 description 2
• YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical compound C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 2
• RUBFYJIMDRUFQC-UHFFFAOYSA-N 2-methyl-5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound N1=C2SC(C)=NC2=CC=C1C1(C=2C=CC=CC=2)CC1 RUBFYJIMDRUFQC-UHFFFAOYSA-N 0.000 description 2
• JTMBNSLNBOQTMP-UHFFFAOYSA-N 2-methyl-5-(1-phenylethenyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound N1=C2SC(C)=NC2=CC=C1C(=C)C1=CC=CC=C1 JTMBNSLNBOQTMP-UHFFFAOYSA-N 0.000 description 2
• GUGQQGROXHPINL-UHFFFAOYSA-N 2-oxobutanoyl chloride Chemical compound CCC(=O)C(Cl)=O GUGQQGROXHPINL-UHFFFAOYSA-N 0.000 description 2
• URVRCFABAVMFKP-UHFFFAOYSA-N 3,6-dichloropyridin-2-amine Chemical compound NC1=NC(Cl)=CC=C1Cl URVRCFABAVMFKP-UHFFFAOYSA-N 0.000 description 2
• FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 2
• PHRZYRFYXILZGS-UHFFFAOYSA-N 3-[2-(2-fluoro-4-methylphenyl)-[1,3]thiazolo[5,4-b]pyridin-5-yl]-3-phenylcyclobutan-1-one Chemical compound FC1=CC(C)=CC=C1C1=NC2=CC=C(C3(CC(=O)C3)C=3C=CC=CC=3)N=C2S1 PHRZYRFYXILZGS-UHFFFAOYSA-N 0.000 description 2
• FQYFGWGKFYQDOL-UHFFFAOYSA-N 3-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 FQYFGWGKFYQDOL-UHFFFAOYSA-N 0.000 description 2
• GPGDXOFKJSFQTA-NTISSMGPSA-N 3-[[(1s)-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethyl]amino]propanoic acid;hydrochloride Chemical compound Cl.FC1=CC([C@@H](NCCC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 GPGDXOFKJSFQTA-NTISSMGPSA-N 0.000 description 2
• LQFBUKSMYSXBTE-UHFFFAOYSA-N 3-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzoyl]amino]propanoic acid Chemical compound FC1=CC(C(=O)NCCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 LQFBUKSMYSXBTE-UHFFFAOYSA-N 0.000 description 2
• HUFCVXIPBONFBC-UHFFFAOYSA-N 3-amino-6-(1-phenylcyclopropyl)-1h-pyridine-2-thione Chemical compound N1C(=S)C(N)=CC=C1C1(C=2C=CC=CC=2)CC1 HUFCVXIPBONFBC-UHFFFAOYSA-N 0.000 description 2
• OMGGHUGJCMMBAC-UHFFFAOYSA-N 3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzonitrile Chemical compound FC1=CC(C#N)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 OMGGHUGJCMMBAC-UHFFFAOYSA-N 0.000 description 2
• IYBMPKVKYNQVBW-UHFFFAOYSA-N 3-fluoro-4-[5-[1-(4-phenylmethoxyphenyl)cyclopropyl]-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzaldehyde Chemical compound FC1=CC(C=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC(OCC=4C=CC=CC=4)=CC=3)N=C2S1 IYBMPKVKYNQVBW-UHFFFAOYSA-N 0.000 description 2
• DDUJJZVUPLAGQO-UHFFFAOYSA-N 3-fluoro-4-[6-(1-phenylcyclopropyl)-1,3-benzothiazol-2-yl]benzaldehyde Chemical compound FC1=CC(C=O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)C=C2S1 DDUJJZVUPLAGQO-UHFFFAOYSA-N 0.000 description 2
• OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
• GDAWXQGLJOGFBD-UHFFFAOYSA-N 4-(5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl)-3-fluorobenzaldehyde Chemical compound FC1=CC(C=O)=CC=C1C1=NC2=CC=C(Cl)N=C2S1 GDAWXQGLJOGFBD-UHFFFAOYSA-N 0.000 description 2
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
• JFRPWJDOGGLZFS-UHFFFAOYSA-N 4-bromo-2,6-dimethylbenzaldehyde Chemical compound CC1=CC(Br)=CC(C)=C1C=O JFRPWJDOGGLZFS-UHFFFAOYSA-N 0.000 description 2
• LAYDFDMDUCVHBO-UHFFFAOYSA-N 4-bromo-2,6-dimethylbenzonitrile Chemical compound CC1=CC(Br)=CC(C)=C1C#N LAYDFDMDUCVHBO-UHFFFAOYSA-N 0.000 description 2
• YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
• WNVSEVCZYIZPLF-UHFFFAOYSA-N 5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine-2-carboxylic acid Chemical compound N1=C2SC(C(=O)O)=NC2=CC=C1C1(C=2C=CC=CC=2)CC1 WNVSEVCZYIZPLF-UHFFFAOYSA-N 0.000 description 2
• KJCUJYSSIPDWSZ-UHFFFAOYSA-N 5-benzyl-2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2CC1=CC=CC=C1 KJCUJYSSIPDWSZ-UHFFFAOYSA-N 0.000 description 2
• KFVPDFLSSUNRFU-UHFFFAOYSA-N 6-bromo-2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-1,3-benzothiazole Chemical compound C=1C=C(C=2SC3=CC(Br)=CC=C3N=2)C(F)=CC=1C1OCCCO1 KFVPDFLSSUNRFU-UHFFFAOYSA-N 0.000 description 2
• IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 2
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 2
• 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 2
• 206010067484 Adverse reaction Diseases 0.000 description 2
• 241000416162 Astragalus gummifer Species 0.000 description 2
• 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 2
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 2
• 208000009137 Behcet syndrome Diseases 0.000 description 2
• KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
• 241000167854 Bourreria succulenta Species 0.000 description 2
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 2
• 108010036949 Cyclosporine Proteins 0.000 description 2
• 235000019739 Dicalciumphosphate Nutrition 0.000 description 2
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
• 206010018364 Glomerulonephritis Diseases 0.000 description 2
• 206010072579 Granulomatosis with polyangiitis Diseases 0.000 description 2
• 101001038001 Homo sapiens Lysophosphatidic acid receptor 2 Proteins 0.000 description 2
• 101001038006 Homo sapiens Lysophosphatidic acid receptor 3 Proteins 0.000 description 2
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical group C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
• 206010061218 Inflammation Diseases 0.000 description 2
• FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 2
• 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
• 240000007472 Leucaena leucocephala Species 0.000 description 2
• 208000019693 Lung disease Diseases 0.000 description 2
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
• 206010025323 Lymphomas Diseases 0.000 description 2
• 102100040387 Lysophosphatidic acid receptor 2 Human genes 0.000 description 2
• 102100040388 Lysophosphatidic acid receptor 3 Human genes 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
• 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
• 235000019483 Peanut oil Nutrition 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 2
• XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
• 206010063837 Reperfusion injury Diseases 0.000 description 2
• 229920001800 Shellac Polymers 0.000 description 2
• 102100025747 Sphingosine 1-phosphate receptor 3 Human genes 0.000 description 2
• 102100029802 Sphingosine 1-phosphate receptor 5 Human genes 0.000 description 2
• 229920001615 Tragacanth Polymers 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• 206010046851 Uveitis Diseases 0.000 description 2
• WNYNTTHPKLDSKB-UHFFFAOYSA-N [2-[2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-1,3-benzothiazol-6-yl]-2-phenylcyclopropyl]-trimethylsilane Chemical compound C[Si](C)(C)C1CC1(C=1C=C2SC(=NC2=CC=1)C=1C(=CC(=CC=1)C1OCCCO1)F)C1=CC=CC=C1 WNYNTTHPKLDSKB-UHFFFAOYSA-N 0.000 description 2
• JJTNXAUCMXHALQ-UHFFFAOYSA-N [2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-[1,3]thiazolo[5,4-b]pyridin-5-yl]-phenylmethanol Chemical compound C=1C=C2N=C(C=3C(=CC(=CC=3)C3OCCCO3)F)SC2=NC=1C(O)C1=CC=CC=C1 JJTNXAUCMXHALQ-UHFFFAOYSA-N 0.000 description 2
• PNGALFCCLZXDMU-UHFFFAOYSA-N [2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-[1,3]thiazolo[5,4-b]pyridin-5-yl]-phenylmethanone Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2C(=O)C1=CC=CC=C1 PNGALFCCLZXDMU-UHFFFAOYSA-N 0.000 description 2
• DDIASSZTDCXRCN-UHFFFAOYSA-N [2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-[1,3]thiazolo[5,4-b]pyridin-5-yl]-trimethylstannane Chemical compound S1C2=NC([Sn](C)(C)C)=CC=C2N=C1C(C(=C1)F)=CC=C1C1OCCCO1 DDIASSZTDCXRCN-UHFFFAOYSA-N 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• 239000003070 absorption delaying agent Substances 0.000 description 2
• 125000002252 acyl group Chemical group 0.000 description 2
• 201000000028 adult respiratory distress syndrome Diseases 0.000 description 2
• 230000006838 adverse reaction Effects 0.000 description 2
• 235000010443 alginic acid Nutrition 0.000 description 2
• 229920000615 alginic acid Polymers 0.000 description 2
• 125000003282 alkyl amino group Chemical group 0.000 description 2
• 235000019270 ammonium chloride Nutrition 0.000 description 2
• 238000010171 animal model Methods 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 206010003246 arthritis Diseases 0.000 description 2
• 208000006673 asthma Diseases 0.000 description 2
• 229960002170 azathioprine Drugs 0.000 description 2
• LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 2
• 125000002393 azetidinyl group Chemical group 0.000 description 2
• 150000001555 benzenes Chemical class 0.000 description 2
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
• QHORRKSZGBYGPH-UHFFFAOYSA-L benzylidene(dichloro)ruthenium Chemical compound Cl[Ru](Cl)=CC1=CC=CC=C1 QHORRKSZGBYGPH-UHFFFAOYSA-L 0.000 description 2
• 239000011230 binding agent Substances 0.000 description 2
• 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
• 239000001506 calcium phosphate Substances 0.000 description 2
• 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
• 239000001768 carboxy methyl cellulose Substances 0.000 description 2
• 239000003054 catalyst Substances 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 230000008859 change Effects 0.000 description 2
• 235000019693 cherries Nutrition 0.000 description 2
• 229960004926 chlorobutanol Drugs 0.000 description 2
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 2
• 229960001265 ciclosporin Drugs 0.000 description 2
• LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
• 239000003246 corticosteroid Substances 0.000 description 2
• 229960001334 corticosteroids Drugs 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 239000012043 crude product Substances 0.000 description 2
• CCQPAEQGAVNNIA-UHFFFAOYSA-L cyclobutane-1,1-dicarboxylate(2-) Chemical compound [O-]C(=O)C1(C([O-])=O)CCC1 CCQPAEQGAVNNIA-UHFFFAOYSA-L 0.000 description 2
• TXWOGHSRPAYOML-UHFFFAOYSA-N cyclobutanecarboxylic acid Chemical compound OC(=O)C1CCC1 TXWOGHSRPAYOML-UHFFFAOYSA-N 0.000 description 2
• 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
• IGARGHRYKHJQSM-UHFFFAOYSA-N cyclohexylbenzene Chemical compound C1CCCCC1C1=CC=CC=C1 IGARGHRYKHJQSM-UHFFFAOYSA-N 0.000 description 2
• 229960004397 cyclophosphamide Drugs 0.000 description 2
• 229930182912 cyclosporin Natural products 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 229940119744 dextran 40 Drugs 0.000 description 2
• 229940119743 dextran 70 Drugs 0.000 description 2
• NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 2
• 229940038472 dicalcium phosphate Drugs 0.000 description 2
• 229910000390 dicalcium phosphate Inorganic materials 0.000 description 2
• CEVCRAJVGQECAV-UHFFFAOYSA-N diethyl 2-(1-benzhydrylazetidin-3-yl)propanedioate Chemical compound C1C(C(C(=O)OCC)C(=O)OCC)CN1C(C=1C=CC=CC=1)C1=CC=CC=C1 CEVCRAJVGQECAV-UHFFFAOYSA-N 0.000 description 2
• KTCLYNBSLIGGFX-UHFFFAOYSA-N diethyl 2-[1-[(2-methylpropan-2-yl)oxycarbonyl]azetidin-3-yl]propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)C1CN(C(=O)OC(C)(C)C)C1 KTCLYNBSLIGGFX-UHFFFAOYSA-N 0.000 description 2
• NZZFYRREKKOMAT-UHFFFAOYSA-N diiodomethane Chemical compound ICI NZZFYRREKKOMAT-UHFFFAOYSA-N 0.000 description 2
• 229940043279 diisopropylamine Drugs 0.000 description 2
• 239000012636 effector Substances 0.000 description 2
• 239000012055 enteric layer Substances 0.000 description 2
• JEAJBJPNFQSKSA-UHFFFAOYSA-N ethyl 2-[(2,6-dichloropyridin-3-yl)amino]-2-oxoacetate Chemical compound CCOC(=O)C(=O)NC1=CC=C(Cl)N=C1Cl JEAJBJPNFQSKSA-UHFFFAOYSA-N 0.000 description 2
• GRNHSYMOGNVVNW-UHFFFAOYSA-N ethyl 2-[(2,6-dichloropyridin-3-yl)amino]-2-sulfanylideneacetate Chemical compound CCOC(=O)C(=S)NC1=CC=C(Cl)N=C1Cl GRNHSYMOGNVVNW-UHFFFAOYSA-N 0.000 description 2
• WTPAWQQJCMEFFG-UHFFFAOYSA-N ethyl 5-chloro-[1,3]thiazolo[5,4-b]pyridine-2-carboxylate Chemical compound C1=C(Cl)N=C2SC(C(=O)OCC)=NC2=C1 WTPAWQQJCMEFFG-UHFFFAOYSA-N 0.000 description 2
• UGRVUSWSAGRCSJ-UHFFFAOYSA-N ethylammonium trifluoroacetate Chemical compound CC[NH3+].[O-]C(=O)C(F)(F)F UGRVUSWSAGRCSJ-UHFFFAOYSA-N 0.000 description 2
• 208000012997 experimental autoimmune encephalomyelitis Diseases 0.000 description 2
• 230000004761 fibrosis Effects 0.000 description 2
• 239000012530 fluid Substances 0.000 description 2
• 235000003599 food sweetener Nutrition 0.000 description 2
• 235000019253 formic acid Nutrition 0.000 description 2
• 239000007789 gas Substances 0.000 description 2
• 238000007429 general method Methods 0.000 description 2
• 229960005150 glycerol Drugs 0.000 description 2
• 229910052736 halogen Inorganic materials 0.000 description 2
• 150000002367 halogens Chemical class 0.000 description 2
• 210000002216 heart Anatomy 0.000 description 2
• BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
• 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 2
• 125000002883 imidazolyl group Chemical group 0.000 description 2
• 230000002519 immonomodulatory effect Effects 0.000 description 2
• 208000026278 immune system disease Diseases 0.000 description 2
• 239000003018 immunosuppressive agent Substances 0.000 description 2
• 238000011065 in-situ storage Methods 0.000 description 2
• 230000001939 inductive effect Effects 0.000 description 2
• 230000008595 infiltration Effects 0.000 description 2
• 238000001764 infiltration Methods 0.000 description 2
• 230000004054 inflammatory process Effects 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 238000007918 intramuscular administration Methods 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 238000010253 intravenous injection Methods 0.000 description 2
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
• 208000028867 ischemia Diseases 0.000 description 2
• 208000012947 ischemia reperfusion injury Diseases 0.000 description 2
• 210000004153 islets of langerhan Anatomy 0.000 description 2
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
• 210000003734 kidney Anatomy 0.000 description 2
• JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
• GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium;hydroxide;hydrate Chemical compound [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 2
• 210000004072 lung Anatomy 0.000 description 2
• 206010025135 lupus erythematosus Diseases 0.000 description 2
• FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 2
• NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
• QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
• 229960000485 methotrexate Drugs 0.000 description 2
• ZDHBVCASMMWVMV-UHFFFAOYSA-N methyl 3-hydroxyazetidine-3-carboxylate Chemical compound COC(=O)C1(O)CNC1 ZDHBVCASMMWVMV-UHFFFAOYSA-N 0.000 description 2
• 229920000609 methyl cellulose Polymers 0.000 description 2
• 239000001923 methylcellulose Substances 0.000 description 2
• 235000010981 methylcellulose Nutrition 0.000 description 2
• 229960002900 methylcellulose Drugs 0.000 description 2
• 125000002950 monocyclic group Chemical group 0.000 description 2
• 206010028417 myasthenia gravis Diseases 0.000 description 2
• FHVDCZKBXKPLIL-UHFFFAOYSA-N n-(3,6-dichloropyridin-2-yl)-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=NC(Cl)=CC=C1Cl FHVDCZKBXKPLIL-UHFFFAOYSA-N 0.000 description 2
• YPWKLBCTOUEZKE-UHFFFAOYSA-N n-(6-chloropyridin-2-yl)-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=CC=CC(Cl)=N1 YPWKLBCTOUEZKE-UHFFFAOYSA-N 0.000 description 2
• 239000006199 nebulizer Substances 0.000 description 2
• 230000007935 neutral effect Effects 0.000 description 2
• 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
• 150000007524 organic acids Chemical class 0.000 description 2
• KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 239000000312 peanut oil Substances 0.000 description 2
• 230000007414 peripheral immune response Effects 0.000 description 2
• 239000008194 pharmaceutical composition Substances 0.000 description 2
• 239000008024 pharmaceutical diluent Substances 0.000 description 2
• NHKJPPKXDNZFBJ-UHFFFAOYSA-N phenyllithium Chemical compound [Li]C1=CC=CC=C1 NHKJPPKXDNZFBJ-UHFFFAOYSA-N 0.000 description 2
• 230000001766 physiological effect Effects 0.000 description 2
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
• 102000004196 processed proteins & peptides Human genes 0.000 description 2
• 108090000765 processed proteins & peptides Proteins 0.000 description 2
• 235000018102 proteins Nutrition 0.000 description 2
• 102000004169 proteins and genes Human genes 0.000 description 2
• 108090000623 proteins and genes Proteins 0.000 description 2
• 125000000719 pyrrolidinyl group Chemical group 0.000 description 2
• 229940075993 receptor modulator Drugs 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
• YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
• 229930195734 saturated hydrocarbon Natural products 0.000 description 2
• 210000005212 secondary lymphoid organ Anatomy 0.000 description 2
• 238000005204 segregation Methods 0.000 description 2
• 239000008159 sesame oil Substances 0.000 description 2
• 235000011803 sesame oil Nutrition 0.000 description 2
• 239000004208 shellac Substances 0.000 description 2
• 229940113147 shellac Drugs 0.000 description 2
• ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 2
• 235000013874 shellac Nutrition 0.000 description 2
• 230000011664 signaling Effects 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 2
• 239000012279 sodium borohydride Substances 0.000 description 2
• 229910000033 sodium borohydride Inorganic materials 0.000 description 2
• LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
• 235000010265 sodium sulphite Nutrition 0.000 description 2
• MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
• 239000008247 solid mixture Substances 0.000 description 2
• 230000003595 spectral effect Effects 0.000 description 2
• VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical group COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 238000003860 storage Methods 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
• 235000000346 sugar Nutrition 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 230000002459 sustained effect Effects 0.000 description 2
• 239000003765 sweetening agent Substances 0.000 description 2
• 239000006188 syrup Substances 0.000 description 2
• 235000020357 syrup Nutrition 0.000 description 2
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 2
• HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
• 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 2
• 238000002560 therapeutic procedure Methods 0.000 description 2
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 2
• 229940033663 thimerosal Drugs 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• 229910052723 transition metal Inorganic materials 0.000 description 2
• 150000003624 transition metals Chemical class 0.000 description 2
• 230000032258 transport Effects 0.000 description 2
• WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 2
• WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
• QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
• ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 2
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
• JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
• WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
• AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical class C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
• QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
• ZZMYWYZPNZRYPX-SANMLTNESA-N (2r)-2-amino-2-[5-[4-[2-(4-phenylphenyl)ethoxy]-3-(trifluoromethyl)phenyl]-1h-imidazol-2-yl]propan-1-ol Chemical compound N1C([C@@](N)(CO)C)=NC=C1C(C=C1C(F)(F)F)=CC=C1OCCC1=CC=C(C=2C=CC=CC=2)C=C1 ZZMYWYZPNZRYPX-SANMLTNESA-N 0.000 description 1
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
• ITABOOWBVLCBIV-GMUIIQOCSA-N (3r)-1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]pyrrolidine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1[C@H](C(=O)O)CCN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ITABOOWBVLCBIV-GMUIIQOCSA-N 0.000 description 1
• ITABOOWBVLCBIV-FERBBOLQSA-N (3s)-1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]pyrrolidine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1[C@@H](C(=O)O)CCN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 ITABOOWBVLCBIV-FERBBOLQSA-N 0.000 description 1
• MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
• BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
• NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 1
• QMATYTFXDIWACW-UHFFFAOYSA-N 1-(2-fluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC=C1F QMATYTFXDIWACW-UHFFFAOYSA-N 0.000 description 1
• ZDPAWHACYDRYIW-UHFFFAOYSA-N 1-(4-fluorophenyl)ethanone Chemical compound CC(=O)C1=CC=C(F)C=C1 ZDPAWHACYDRYIW-UHFFFAOYSA-N 0.000 description 1
• MKYMYZJJFMPDOA-UHFFFAOYSA-N 1-(4-phenylmethoxyphenyl)ethanone Chemical compound C1=CC(C(=O)C)=CC=C1OCC1=CC=CC=C1 MKYMYZJJFMPDOA-UHFFFAOYSA-N 0.000 description 1
• OHTBJFABCNOWJW-GNAFDRTKSA-N 1-[(1r)-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]propyl]azetidine-3-carboxylic acid;hydrochloride Chemical compound Cl.N1([C@H](CC)C=2C=C(F)C(C=3SC4=NC(=CC=C4N=3)C3(CC3)C=3C=CC=CC=3)=CC=2)CC(C(O)=O)C1 OHTBJFABCNOWJW-GNAFDRTKSA-N 0.000 description 1
• UBBOOQMRDPNMTK-UHFFFAOYSA-N 1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]propan-1-one Chemical compound FC1=CC(C(=O)CC)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 UBBOOQMRDPNMTK-UHFFFAOYSA-N 0.000 description 1
• QPYSZWMSKQMZMB-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]-1-oxidoazetidin-1-ium-3-carboxylic acid Chemical compound C1C(C(=O)O)C[N+]1([O-])CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 QPYSZWMSKQMZMB-UHFFFAOYSA-N 0.000 description 1
• HQQYYYPPNUZAQL-UHFFFAOYSA-N 1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]-3-hydroxyazetidine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1C(C(=O)O)(O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 HQQYYYPPNUZAQL-UHFFFAOYSA-N 0.000 description 1
• ABHLOECHIZIMCU-UHFFFAOYSA-N 1-[[3-fluoro-4-[6-(1-phenylcyclopropyl)-1,3-benzothiazol-2-yl]phenyl]methyl]azetidine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)C=C2S1 ABHLOECHIZIMCU-UHFFFAOYSA-N 0.000 description 1
• HMMAVOLMFVUBPG-UHFFFAOYSA-N 1-[[3-fluoro-4-[6-(1-phenylcyclopropyl)-[1,3]thiazolo[4,5-c]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1C(C(=O)O)CN1CC(C=C1F)=CC=C1C1=NC2=CN=C(C3(CC3)C=3C=CC=CC=3)C=C2S1 HMMAVOLMFVUBPG-UHFFFAOYSA-N 0.000 description 1
• MMAJXKGUZYDTHV-UHFFFAOYSA-N 1-benzhydrylazetidin-3-ol Chemical compound C1C(O)CN1C(C=1C=CC=CC=1)C1=CC=CC=C1 MMAJXKGUZYDTHV-UHFFFAOYSA-N 0.000 description 1
• SLFNGVGRINFJLK-UHFFFAOYSA-N 1-bromo-2-fluoro-4-methylbenzene Chemical compound CC1=CC=C(Br)C(F)=C1 SLFNGVGRINFJLK-UHFFFAOYSA-N 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• RRSOPONADDSNNE-UHFFFAOYSA-N 1-phenylethenylboronic acid;hydrate Chemical compound O.OB(O)C(=C)C1=CC=CC=C1 RRSOPONADDSNNE-UHFFFAOYSA-N 0.000 description 1
• FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
• XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 1
• OHDAURMSEHMPFJ-UHFFFAOYSA-N 2,2,2-trifluoro-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanol Chemical compound FC1=CC(C(O)C(F)(F)F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 OHDAURMSEHMPFJ-UHFFFAOYSA-N 0.000 description 1
• JXFMBYVQQMCCFI-UHFFFAOYSA-N 2,2,2-trifluoro-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethanone Chemical compound FC1=CC(C(=O)C(F)(F)F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 JXFMBYVQQMCCFI-UHFFFAOYSA-N 0.000 description 1
• JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
• FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
• UWKQJZCTQGMHKD-UHFFFAOYSA-N 2,6-di-tert-butylpyridine Chemical compound CC(C)(C)C1=CC=CC(C(C)(C)C)=N1 UWKQJZCTQGMHKD-UHFFFAOYSA-N 0.000 description 1
• BOXVMFGWCZEURD-UHFFFAOYSA-N 2,6-dibromo-3-isothiocyanatopyridine Chemical compound BrC1=CC=C(N=C=S)C(Br)=N1 BOXVMFGWCZEURD-UHFFFAOYSA-N 0.000 description 1
• OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
• LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
• NOEKTHLORQYFPM-UHFFFAOYSA-N 2-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]propan-2-ol Chemical compound FC1=CC(C(C)(O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 NOEKTHLORQYFPM-UHFFFAOYSA-N 0.000 description 1
• WQGGIWNYLLNNDO-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-(1-phenylcyclopropyl)-[1,3]thiazolo[4,5-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=CC=2)=NC1=NC=2C1(C=2C=CC=CC=2)CC1 WQGGIWNYLLNNDO-UHFFFAOYSA-N 0.000 description 1
• QJDSKZTWLZWFAZ-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-(1-phenylpent-4-enyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2C(CCC=C)C1=CC=CC=C1 QJDSKZTWLZWFAZ-UHFFFAOYSA-N 0.000 description 1
• PSERPERXMWISPP-UHFFFAOYSA-N 2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-5-[1-(4-phenylmethoxyphenyl)ethenyl]-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(C2OCCCO2)=CC=C1C(SC1=N2)=NC1=CC=C2C(=C)C(C=C1)=CC=C1OCC1=CC=CC=C1 PSERPERXMWISPP-UHFFFAOYSA-N 0.000 description 1
• IIBIKRJGVLRAMH-UHFFFAOYSA-N 2-[4-[3-bromo-2-(bromomethyl)propyl]-2-fluorophenyl]-5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridine Chemical compound FC1=CC(CC(CBr)CBr)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 IIBIKRJGVLRAMH-UHFFFAOYSA-N 0.000 description 1
• TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
• 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
• 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
• NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical class C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 description 1
• BZSXEZOLBIJVQK-UHFFFAOYSA-N 2-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1C(O)=O BZSXEZOLBIJVQK-UHFFFAOYSA-N 0.000 description 1
• WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
• CDBAEFXTCRKJPZ-UHFFFAOYSA-N 3,3-difluoroazetidine;hydron;chloride Chemical compound Cl.FC1(F)CNC1 CDBAEFXTCRKJPZ-UHFFFAOYSA-N 0.000 description 1
• RFGJHINPCDRYLC-UHFFFAOYSA-N 3,6-dichloro-2-isothiocyanatopyridine Chemical compound ClC1=CC=C(Cl)C(N=C=S)=N1 RFGJHINPCDRYLC-UHFFFAOYSA-N 0.000 description 1
• JKVNBVAXCROKNI-UHFFFAOYSA-N 3-[3-fluoro-n-methyl-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]anilino]propanoic acid;hydrochloride Chemical compound Cl.FC1=CC(N(CCC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 JKVNBVAXCROKNI-UHFFFAOYSA-N 0.000 description 1
• GPGDXOFKJSFQTA-PKLMIRHRSA-N 3-[[(1r)-1-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]ethyl]amino]propanoic acid;hydrochloride Chemical compound Cl.FC1=CC([C@H](NCCC(O)=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 GPGDXOFKJSFQTA-PKLMIRHRSA-N 0.000 description 1
• RJSAJUMQUMSYHG-UHFFFAOYSA-N 3-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methylamino]propanoic acid;hydrochloride Chemical compound Cl.FC1=CC(CNCCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 RJSAJUMQUMSYHG-UHFFFAOYSA-N 0.000 description 1
• BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
• NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
• UWVTZIBZAOOJFF-UHFFFAOYSA-N 3-fluoro-1-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]methyl]azetidine-3-carboxylic acid;hydrochloride Chemical compound Cl.C1C(C(=O)O)(F)CN1CC(C=C1F)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 UWVTZIBZAOOJFF-UHFFFAOYSA-N 0.000 description 1
• PIWBCXHDYGIEBK-UHFFFAOYSA-N 3-fluoro-4-[5-(1-phenylcyclohexyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzaldehyde Chemical compound FC1=CC(C=O)=CC=C1C1=NC2=CC=C(C3(CCCCC3)C=3C=CC=CC=3)N=C2S1 PIWBCXHDYGIEBK-UHFFFAOYSA-N 0.000 description 1
• LWLGCPWGFGCIOC-UHFFFAOYSA-N 3-fluoro-4-[5-(1-phenylcyclopent-3-en-1-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzaldehyde Chemical compound FC1=CC(C=O)=CC=C1C1=NC2=CC=C(C3(CC=CC3)C=3C=CC=CC=3)N=C2S1 LWLGCPWGFGCIOC-UHFFFAOYSA-N 0.000 description 1
• BVERKCVTGJHDGQ-UHFFFAOYSA-N 3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzamide Chemical compound FC1=CC(C(=O)N)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 BVERKCVTGJHDGQ-UHFFFAOYSA-N 0.000 description 1
• FBGVTWONYOCYGA-UHFFFAOYSA-N 4,6-dichloropyridin-3-amine Chemical compound NC1=CN=C(Cl)C=C1Cl FBGVTWONYOCYGA-UHFFFAOYSA-N 0.000 description 1
• CPZNHEBXQUGQPL-UHFFFAOYSA-N 4-[[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]benzoyl]amino]butanoic acid Chemical compound FC1=CC(C(=O)NCCCC(=O)O)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 CPZNHEBXQUGQPL-UHFFFAOYSA-N 0.000 description 1
• QGLAYJCJLHNIGJ-UHFFFAOYSA-N 4-bromo-2,6-dimethylaniline Chemical compound CC1=CC(Br)=CC(C)=C1N QGLAYJCJLHNIGJ-UHFFFAOYSA-N 0.000 description 1
• PWOPDCSAVIMSPX-UHFFFAOYSA-N 4-bromo-2-fluoro-1-isothiocyanatobenzene Chemical compound FC1=CC(Br)=CC=C1N=C=S PWOPDCSAVIMSPX-UHFFFAOYSA-N 0.000 description 1
• GZRMNMGWNKSANY-UHFFFAOYSA-N 4-bromo-2-fluoroaniline Chemical compound NC1=CC=C(Br)C=C1F GZRMNMGWNKSANY-UHFFFAOYSA-N 0.000 description 1
• LPEBMDFRIKYFCF-UHFFFAOYSA-N 4-bromo-2-methylbenzonitrile Chemical compound CC1=CC(Br)=CC=C1C#N LPEBMDFRIKYFCF-UHFFFAOYSA-N 0.000 description 1
• SWHUROFMIMHWKS-UHFFFAOYSA-N 4-bromo-3-fluorobenzaldehyde Chemical compound FC1=CC(C=O)=CC=C1Br SWHUROFMIMHWKS-UHFFFAOYSA-N 0.000 description 1
• SKXUZFJOLNNWIG-UHFFFAOYSA-N 4-bromo-3-methylbenzonitrile Chemical compound CC1=CC(C#N)=CC=C1Br SKXUZFJOLNNWIG-UHFFFAOYSA-N 0.000 description 1
• DMAYBPBPEUFIHJ-UHFFFAOYSA-N 4-bromobut-1-ene Chemical compound BrCCC=C DMAYBPBPEUFIHJ-UHFFFAOYSA-N 0.000 description 1
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
• IQTHEAQKKVAXGV-UHFFFAOYSA-N 4-ditert-butylphosphanyl-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(P(C(C)(C)C)C(C)(C)C)C=C1 IQTHEAQKKVAXGV-UHFFFAOYSA-N 0.000 description 1
• SXIFAEWFOJETOA-UHFFFAOYSA-N 4-hydroxy-butyl Chemical group [CH2]CCCO SXIFAEWFOJETOA-UHFFFAOYSA-N 0.000 description 1
• ICGLPKIVTVWCFT-UHFFFAOYSA-N 4-methylbenzenesulfonohydrazide Chemical compound CC1=CC=C(S(=O)(=O)NN)C=C1 ICGLPKIVTVWCFT-UHFFFAOYSA-N 0.000 description 1
• ILAIPOOQUOIKFG-UHFFFAOYSA-N 5-chloro-2-[4-(1,3-dioxan-2-yl)-2-fluorophenyl]-[1,3]thiazolo[4,5-b]pyridine Chemical compound C=1C=C(C=2SC3=CC=C(Cl)N=C3N=2)C(F)=CC=1C1OCCCO1 ILAIPOOQUOIKFG-UHFFFAOYSA-N 0.000 description 1
• QZKHWZUBIKKZEY-UHFFFAOYSA-N 5-chloro-2-methyl-[1,3]thiazolo[5,4-b]pyridine Chemical compound C1=C(Cl)N=C2SC(C)=NC2=C1 QZKHWZUBIKKZEY-UHFFFAOYSA-N 0.000 description 1
• OBYJTLDIQBWBHM-UHFFFAOYSA-N 6-chloropyridin-2-amine Chemical compound NC1=CC=CC(Cl)=N1 OBYJTLDIQBWBHM-UHFFFAOYSA-N 0.000 description 1
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
• OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 229910000497 Amalgam Inorganic materials 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
• 201000005670 Anovulation Diseases 0.000 description 1
• 206010002659 Anovulatory cycle Diseases 0.000 description 1
• 206010003827 Autoimmune hepatitis Diseases 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• 206010006187 Breast cancer Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 238000006418 Brown reaction Methods 0.000 description 1
• VXLHQRVEHQEWHI-UHFFFAOYSA-N C1(=CC=CC=C1)C1(CC1)C(C(=O)C1=CC=CC=C1)C=1SC2=NC=CC=C2N=1 Chemical compound C1(=CC=CC=C1)C1(CC1)C(C(=O)C1=CC=CC=C1)C=1SC2=NC=CC=C2N=1 VXLHQRVEHQEWHI-UHFFFAOYSA-N 0.000 description 1
• SFOGPLBOVSKNNZ-UHFFFAOYSA-N C1CC1(C2=CC=CC=C2)C3=NC4=C(C=C3)N=C(S4)C5=C(C=C(C=C5)CCC(CO)CO)F Chemical compound C1CC1(C2=CC=CC=C2)C3=NC4=C(C=C3)N=C(S4)C5=C(C=C(C=C5)CCC(CO)CO)F SFOGPLBOVSKNNZ-UHFFFAOYSA-N 0.000 description 1
• AUKRDHUZXVNZHX-UHFFFAOYSA-N C1CCC(C1)(C2=CC=CC=C2)C3=NC4=C(C=C3)N=C(S4)C5=C(C=C(C=C5)CN6CCC6)F Chemical compound C1CCC(C1)(C2=CC=CC=C2)C3=NC4=C(C=C3)N=C(S4)C5=C(C=C(C=C5)CN6CCC6)F AUKRDHUZXVNZHX-UHFFFAOYSA-N 0.000 description 1
• WWMYRNZVBAJGRN-UHFFFAOYSA-N CC(C)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F Chemical compound CC(C)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F WWMYRNZVBAJGRN-UHFFFAOYSA-N 0.000 description 1
• DFXLHCVCXVXNEJ-UHFFFAOYSA-N CCCCNC(=O)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F Chemical compound CCCCNC(=O)C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F DFXLHCVCXVXNEJ-UHFFFAOYSA-N 0.000 description 1
• XGPWHJWIBKUJEL-QHCPKHFHSA-N CC[C@@H](C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F)N6CCC6 Chemical compound CC[C@@H](C1=CC(=C(C=C1)C2=NC3=C(S2)N=C(C=C3)C4(CC4)C5=CC=CC=C5)F)N6CCC6 XGPWHJWIBKUJEL-QHCPKHFHSA-N 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 description 1
• 206010008909 Chronic Hepatitis Diseases 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
• MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
• HTJDQJBWANPRPF-UHFFFAOYSA-N Cyclopropylamine Chemical compound NC1CC1 HTJDQJBWANPRPF-UHFFFAOYSA-N 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 102000036530 EDG receptors Human genes 0.000 description 1
• 108091007263 EDG receptors Proteins 0.000 description 1
• 206010014733 Endometrial cancer Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 108090000371 Esterases Proteins 0.000 description 1
• XFVACBDOMCOCSN-UHFFFAOYSA-N FC(C(=O)O)(F)F.N1CC(C1)C(=O)O Chemical compound FC(C(=O)O)(F)F.N1CC(C1)C(=O)O XFVACBDOMCOCSN-UHFFFAOYSA-N 0.000 description 1
• UWRHNKKSIBETHA-UHFFFAOYSA-N FC1=CC=CC=C1C(SC1=N2)=NC1=CC(C1OCCCO1)=C2CC1=CC=CC=C1 Chemical compound FC1=CC=CC=C1C(SC1=N2)=NC1=CC(C1OCCCO1)=C2CC1=CC=CC=C1 UWRHNKKSIBETHA-UHFFFAOYSA-N 0.000 description 1
• HLCLLCZHRNNGPV-KRWDZBQOSA-N FC=1C=C(C=CC1C=1SC2=NC(=CC=C2N1)C1(CC1)C1=CC=CC=C1)[C@H](C)N1CCC1 Chemical compound FC=1C=C(C=CC1C=1SC2=NC(=CC=C2N1)C1(CC1)C1=CC=CC=C1)[C@H](C)N1CCC1 HLCLLCZHRNNGPV-KRWDZBQOSA-N 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 239000007818 Grignard reagent Substances 0.000 description 1
• 208000030836 Hashimoto thyroiditis Diseases 0.000 description 1
• 208000035186 Hemolytic Autoimmune Anemia Diseases 0.000 description 1
• 101000966782 Homo sapiens Lysophosphatidic acid receptor 1 Proteins 0.000 description 1
• 101000864393 Homo sapiens Protein BUD31 homolog Proteins 0.000 description 1
• 101000693265 Homo sapiens Sphingosine 1-phosphate receptor 1 Proteins 0.000 description 1
• 101000693269 Homo sapiens Sphingosine 1-phosphate receptor 3 Proteins 0.000 description 1
• 101000653759 Homo sapiens Sphingosine 1-phosphate receptor 5 Proteins 0.000 description 1
• 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
• 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 206010021143 Hypoxia Diseases 0.000 description 1
• 206010061598 Immunodeficiency Diseases 0.000 description 1
• 206010062016 Immunosuppression Diseases 0.000 description 1
• 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
• 208000029523 Interstitial Lung disease Diseases 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 239000004166 Lanolin Substances 0.000 description 1
• 239000004367 Lipase Substances 0.000 description 1
• 108090001060 Lipase Proteins 0.000 description 1
• 102000004882 Lipase Human genes 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 206010025327 Lymphopenia Diseases 0.000 description 1
• 102100040607 Lysophosphatidic acid receptor 1 Human genes 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 1
• 244000246386 Mentha pulegium Species 0.000 description 1
• 235000016257 Mentha pulegium Nutrition 0.000 description 1
• 235000004357 Mentha x piperita Nutrition 0.000 description 1
• RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
• FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 1
• 241000699670 Mus sp. Species 0.000 description 1
• 241000238367 Mya arenaria Species 0.000 description 1
• FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
• QEEWEQZMTHTGGT-UHFFFAOYSA-N N=1C2=CC=CN=C2SC=1C=1C(C(=O)O)=CC=CC=1C1(C=2C=CC=CC=2)CC1 Chemical compound N=1C2=CC=CN=C2SC=1C=1C(C(=O)O)=CC=CC=1C1(C=2C=CC=CC=2)CC1 QEEWEQZMTHTGGT-UHFFFAOYSA-N 0.000 description 1
• LRMWWHYFYMUFFJ-UHFFFAOYSA-N N=1C2=CC=CN=C2SC=1C=1C(C=O)=CC=CC=1C1(C=2C=CC=CC=2)CC1 Chemical compound N=1C2=CC=CN=C2SC=1C=1C(C=O)=CC=CC=1C1(C=2C=CC=CC=2)CC1 LRMWWHYFYMUFFJ-UHFFFAOYSA-N 0.000 description 1
• 208000013901 Nephropathies and tubular disease Diseases 0.000 description 1
• 206010029164 Nephrotic syndrome Diseases 0.000 description 1
• 208000001132 Osteoporosis Diseases 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 208000018737 Parkinson disease Diseases 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 239000004264 Petrolatum Substances 0.000 description 1
• RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 239000004372 Polyvinyl alcohol Substances 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 102100030160 Protein BUD31 homolog Human genes 0.000 description 1
• IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
• 241000220317 Rosa Species 0.000 description 1
• UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
• 102100025749 Sphingosine 1-phosphate receptor 2 Human genes 0.000 description 1
• 101710155462 Sphingosine 1-phosphate receptor 2 Proteins 0.000 description 1
• 101710155457 Sphingosine 1-phosphate receptor 3 Proteins 0.000 description 1
• 102100029803 Sphingosine 1-phosphate receptor 4 Human genes 0.000 description 1
• 101710155458 Sphingosine 1-phosphate receptor 4 Proteins 0.000 description 1
• 101710155451 Sphingosine 1-phosphate receptor 5 Proteins 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 235000021355 Stearic acid Nutrition 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
• FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
• 208000031981 Thrombocytopenic Idiopathic Purpura Diseases 0.000 description 1
• 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 208000002495 Uterine Neoplasms Diseases 0.000 description 1
• 206010057469 Vascular stenosis Diseases 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• LRFKWQGGENFBFO-IBGZPJMESA-N [(2s)-2-amino-2-(hydroxymethyl)-4-(4-octylphenyl)butyl] dihydrogen phosphate Chemical compound CCCCCCCCC1=CC=C(CC[C@](N)(CO)COP(O)(O)=O)C=C1 LRFKWQGGENFBFO-IBGZPJMESA-N 0.000 description 1
• 239000002250 absorbent Substances 0.000 description 1
• 230000002745 absorbent Effects 0.000 description 1
• KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 229940081735 acetylcellulose Drugs 0.000 description 1
• 208000038016 acute inflammation Diseases 0.000 description 1
• 230000006022 acute inflammation Effects 0.000 description 1
• 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
• 150000001299 aldehydes Chemical class 0.000 description 1
• 229940072056 alginate Drugs 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• 150000001336 alkenes Chemical class 0.000 description 1
• 150000001345 alkine derivatives Chemical class 0.000 description 1
• 125000005197 alkyl carbonyloxy alkyl group Chemical group 0.000 description 1
• BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 229940024606 amino acid Drugs 0.000 description 1
• 235000001014 amino acid Nutrition 0.000 description 1
• 150000001413 amino acids Chemical class 0.000 description 1
• VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
• 239000000908 ammonium hydroxide Substances 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 231100000552 anovulation Toxicity 0.000 description 1
• 238000011122 anti-angiogenic therapy Methods 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 230000000845 anti-microbial effect Effects 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000003963 antioxidant agent Substances 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• 238000003556 assay Methods 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 201000000448 autoimmune hemolytic anemia Diseases 0.000 description 1
• 201000003710 autoimmune thrombocytopenic purpura Diseases 0.000 description 1
• 230000005784 autoimmunity Effects 0.000 description 1
• XTKDAFGWCDAMPY-UHFFFAOYSA-N azaperone Chemical compound C1=CC(F)=CC=C1C(=O)CCCN1CCN(C=2N=CC=CC=2)CC1 XTKDAFGWCDAMPY-UHFFFAOYSA-N 0.000 description 1
• UQUPQEUNHVVNKW-UHFFFAOYSA-N azetidin-1-ium-3-ol;chloride Chemical compound Cl.OC1CNC1 UQUPQEUNHVVNKW-UHFFFAOYSA-N 0.000 description 1
• GMWFCJXSQQHBPI-UHFFFAOYSA-N azetidin-3-ol Chemical compound OC1CNC1 GMWFCJXSQQHBPI-UHFFFAOYSA-N 0.000 description 1
• 125000004069 aziridinyl group Chemical group 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 229960000686 benzalkonium chloride Drugs 0.000 description 1
• UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
• 229960001950 benzethonium chloride Drugs 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• 229960004365 benzoic acid Drugs 0.000 description 1
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 229960002537 betamethasone Drugs 0.000 description 1
• UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
• 239000004327 boric acid Substances 0.000 description 1
• 235000010338 boric acid Nutrition 0.000 description 1
• 229910052796 boron Inorganic materials 0.000 description 1
• MCQRPQCQMGVWIQ-UHFFFAOYSA-N boron;methylsulfanylmethane Chemical compound [B].CSC MCQRPQCQMGVWIQ-UHFFFAOYSA-N 0.000 description 1
• 239000006189 buccal tablet Substances 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 239000006172 buffering agent Substances 0.000 description 1
• 125000002837 carbocyclic group Chemical group 0.000 description 1
• 150000001722 carbon compounds Chemical class 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 150000001735 carboxylic acids Chemical class 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 230000005779 cell damage Effects 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 208000037887 cell injury Diseases 0.000 description 1
• 230000004709 cell invasion Effects 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 229920002301 cellulose acetate Polymers 0.000 description 1
• 208000015114 central nervous system disease Diseases 0.000 description 1
• 210000001627 cerebral artery Anatomy 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 229960000541 cetyl alcohol Drugs 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 239000007958 cherry flavor Substances 0.000 description 1
• JCKYGMPEJWAADB-UHFFFAOYSA-N chlorambucil Chemical compound OC(=O)CCCC1=CC=C(N(CCCl)CCCl)C=C1 JCKYGMPEJWAADB-UHFFFAOYSA-N 0.000 description 1
• 229960004630 chlorambucil Drugs 0.000 description 1
• 150000001805 chlorine compounds Chemical class 0.000 description 1
• 125000001309 chloro group Chemical group Cl* 0.000 description 1
• WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 description 1
• 208000020832 chronic kidney disease Diseases 0.000 description 1
• 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
• 230000007882 cirrhosis Effects 0.000 description 1
• 208000019425 cirrhosis of liver Diseases 0.000 description 1
• 235000015165 citric acid Nutrition 0.000 description 1
• 239000008395 clarifying agent Substances 0.000 description 1
• 239000003240 coconut oil Substances 0.000 description 1
• 235000019864 coconut oil Nutrition 0.000 description 1
• 239000012230 colorless oil Substances 0.000 description 1
• 229940125851 compound 27 Drugs 0.000 description 1
• 239000000356 contaminant Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• 239000010949 copper Substances 0.000 description 1
• DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
• 229960004544 cortisone Drugs 0.000 description 1
• 239000006184 cosolvent Substances 0.000 description 1
• 235000012343 cottonseed oil Nutrition 0.000 description 1
• 239000002385 cottonseed oil Substances 0.000 description 1
• 238000011262 co‐therapy Methods 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• CCQPAEQGAVNNIA-UHFFFAOYSA-N cyclobutane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCC1 CCQPAEQGAVNNIA-UHFFFAOYSA-N 0.000 description 1
• 238000005888 cyclopropanation reaction Methods 0.000 description 1
• 125000006317 cyclopropyl amino group Chemical group 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 238000000354 decomposition reaction Methods 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000001934 delay Effects 0.000 description 1
• 238000001212 derivatisation Methods 0.000 description 1
• 229960003662 desonide Drugs 0.000 description 1
• WBGKWQHBNHJJPZ-LECWWXJVSA-N desonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O WBGKWQHBNHJJPZ-LECWWXJVSA-N 0.000 description 1
• 229960002593 desoximetasone Drugs 0.000 description 1
• VWVSBHGCDBMOOT-IIEHVVJPSA-N desoximetasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@@H]2O VWVSBHGCDBMOOT-IIEHVVJPSA-N 0.000 description 1
• UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
• 206010012601 diabetes mellitus Diseases 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• ISOLMABRZPQKOV-UHFFFAOYSA-N diethyl 2-acetamidopropanedioate Chemical compound CCOC(=O)C(NC(C)=O)C(=O)OCC ISOLMABRZPQKOV-UHFFFAOYSA-N 0.000 description 1
• HQWPLXHWEZZGKY-UHFFFAOYSA-N diethylzinc Chemical compound CC[Zn]CC HQWPLXHWEZZGKY-UHFFFAOYSA-N 0.000 description 1
• 230000029087 digestion Effects 0.000 description 1
• 102000038379 digestive enzymes Human genes 0.000 description 1
• 108091007734 digestive enzymes Proteins 0.000 description 1
• UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
• 150000002012 dioxanes Chemical class 0.000 description 1
• 239000007884 disintegrant Substances 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 238000004821 distillation Methods 0.000 description 1
• 230000036267 drug metabolism Effects 0.000 description 1
• 239000003596 drug target Substances 0.000 description 1
• 210000001198 duodenum Anatomy 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 230000002526 effect on cardiovascular system Effects 0.000 description 1
• 238000000132 electrospray ionisation Methods 0.000 description 1
• 230000008030 elimination Effects 0.000 description 1
• 238000003379 elimination reaction Methods 0.000 description 1
• 239000003995 emulsifying agent Substances 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 201000002491 encephalomyelitis Diseases 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 230000026721 endothelial cell chemotaxis Effects 0.000 description 1
• 239000002702 enteric coating Substances 0.000 description 1
• 210000002919 epithelial cell Anatomy 0.000 description 1
• 125000004185 ester group Chemical group 0.000 description 1
• CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
• BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
• 150000002170 ethers Chemical class 0.000 description 1
• SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
• CHDFNIZLAAFFPX-UHFFFAOYSA-N ethoxyethane;oxolane Chemical compound CCOCC.C1CCOC1 CHDFNIZLAAFFPX-UHFFFAOYSA-N 0.000 description 1
• CXVQSUBJMYZELD-UHFFFAOYSA-N ethyl 4-aminobutanoate;hydrochloride Chemical compound [Cl-].CCOC(=O)CCC[NH3+] CXVQSUBJMYZELD-UHFFFAOYSA-N 0.000 description 1
• LVAFUYFBSUAAKU-UHFFFAOYSA-N ethyl 5-(1-phenylethenyl)-[1,3]thiazolo[5,4-b]pyridine-2-carboxylate Chemical compound N1=C2SC(C(=O)OCC)=NC2=CC=C1C(=C)C1=CC=CC=C1 LVAFUYFBSUAAKU-UHFFFAOYSA-N 0.000 description 1
• UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
• UCSVJZQSZZAKLD-UHFFFAOYSA-N ethyl azide Chemical compound CCN=[N+]=[N-] UCSVJZQSZZAKLD-UHFFFAOYSA-N 0.000 description 1
• 230000005713 exacerbation Effects 0.000 description 1
• 238000002474 experimental method Methods 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 208000024711 extrinsic asthma Diseases 0.000 description 1
• 239000003889 eye drop Substances 0.000 description 1
• 229940012356 eye drops Drugs 0.000 description 1
• 239000012065 filter cake Substances 0.000 description 1
• 238000003818 flash chromatography Methods 0.000 description 1
• 239000000796 flavoring agent Substances 0.000 description 1
• 235000020375 flavoured syrup Nutrition 0.000 description 1
• 229960000676 flunisolide Drugs 0.000 description 1
• 238000005187 foaming Methods 0.000 description 1
• 235000013305 food Nutrition 0.000 description 1
• 235000013355 food flavoring agent Nutrition 0.000 description 1
• 239000012458 free base Substances 0.000 description 1
• 238000004108 freeze drying Methods 0.000 description 1
• 238000007710 freezing Methods 0.000 description 1
• 230000008014 freezing Effects 0.000 description 1
• 239000001530 fumaric acid Substances 0.000 description 1
• 235000011087 fumaric acid Nutrition 0.000 description 1
• 230000005714 functional activity Effects 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 238000007306 functionalization reaction Methods 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
• 239000007903 gelatin capsule Substances 0.000 description 1
• 239000012362 glacial acetic acid Substances 0.000 description 1
• 230000001434 glomerular Effects 0.000 description 1
• 206010061989 glomerulosclerosis Diseases 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 229960001031 glucose Drugs 0.000 description 1
• 235000001727 glucose Nutrition 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 229940093915 gynecological organic acid Drugs 0.000 description 1
• 150000008282 halocarbons Chemical class 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 208000007475 hemolytic anemia Diseases 0.000 description 1
• VHHHONWQHHHLTI-UHFFFAOYSA-N hexachloroethane Chemical compound ClC(Cl)(Cl)C(Cl)(Cl)Cl VHHHONWQHHHLTI-UHFFFAOYSA-N 0.000 description 1
• 239000008240 homogeneous mixture Substances 0.000 description 1
• 235000001050 hortel pimenta Nutrition 0.000 description 1
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
• COQRGFWWJBEXRC-UHFFFAOYSA-N hydron;methyl 2-aminoacetate;chloride Chemical compound Cl.COC(=O)CN COQRGFWWJBEXRC-UHFFFAOYSA-N 0.000 description 1
• 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
• 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
• 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
• 230000001146 hypoxic effect Effects 0.000 description 1
• 150000003949 imides Chemical group 0.000 description 1
• 230000036737 immune function Effects 0.000 description 1
• 230000008629 immune suppression Effects 0.000 description 1
• 239000002955 immunomodulating agent Substances 0.000 description 1
• 229940121354 immunomodulator Drugs 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 230000001861 immunosuppressant effect Effects 0.000 description 1
• 229940125721 immunosuppressive agent Drugs 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 238000005462 in vivo assay Methods 0.000 description 1
• 229940097275 indigo Drugs 0.000 description 1
• COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Chemical group CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Chemical group C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
• 239000003701 inert diluent Substances 0.000 description 1
• 239000011261 inert gas Substances 0.000 description 1
• 239000012678 infectious agent Substances 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 230000002757 inflammatory effect Effects 0.000 description 1
• 239000007972 injectable composition Substances 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• KQNPFQTWMSNSAP-UHFFFAOYSA-M isobutyrate Chemical compound CC(C)C([O-])=O KQNPFQTWMSNSAP-UHFFFAOYSA-M 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 125000000842 isoxazolyl group Chemical group 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 235000014655 lactic acid Nutrition 0.000 description 1
• 239000004310 lactic acid Substances 0.000 description 1
• 235000019388 lanolin Nutrition 0.000 description 1
• 229940039717 lanolin Drugs 0.000 description 1
• CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
• 235000019421 lipase Nutrition 0.000 description 1
• 239000002502 liposome Substances 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 239000012280 lithium aluminium hydride Substances 0.000 description 1
• DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
• 238000011866 long-term treatment Methods 0.000 description 1
• 239000000314 lubricant Substances 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 230000029849 luteinization Effects 0.000 description 1
• 210000003563 lymphoid tissue Anatomy 0.000 description 1
• 231100001023 lymphopenia Toxicity 0.000 description 1
• ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
• 239000001095 magnesium carbonate Substances 0.000 description 1
• 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
• BXBLTKZWYAHPKM-UHFFFAOYSA-M magnesium;methanidyl(trimethyl)silane;chloride Chemical compound [Mg+2].[Cl-].C[Si](C)(C)[CH2-] BXBLTKZWYAHPKM-UHFFFAOYSA-M 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 239000011976 maleic acid Substances 0.000 description 1
• 229940098895 maleic acid Drugs 0.000 description 1
• 239000001630 malic acid Substances 0.000 description 1
• 235000011090 malic acid Nutrition 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 229960002510 mandelic acid Drugs 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 235000012054 meals Nutrition 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 230000004060 metabolic process Effects 0.000 description 1
• VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
• 229940098779 methanesulfonic acid Drugs 0.000 description 1
• NTNUDYROPUKXNA-UHFFFAOYSA-N methyl 2-(triphenyl-$l^{5}-phosphanylidene)acetate Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OC)C1=CC=CC=C1 NTNUDYROPUKXNA-UHFFFAOYSA-N 0.000 description 1
• 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
• VVBSXSVVMNGQIN-UHFFFAOYSA-N methyl pyrrolidine-3-carboxylate;hydrochloride Chemical compound Cl.COC(=O)C1CCNC1 VVBSXSVVMNGQIN-UHFFFAOYSA-N 0.000 description 1
• OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
• 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 description 1
• 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
• 229960004584 methylprednisolone Drugs 0.000 description 1
• 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012544 monitoring process Methods 0.000 description 1
• 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
• 235000019799 monosodium phosphate Nutrition 0.000 description 1
• 125000002757 morpholinyl group Chemical group 0.000 description 1
• 210000004400 mucous membrane Anatomy 0.000 description 1
• 210000003205 muscle Anatomy 0.000 description 1
• 210000003007 myelin sheath Anatomy 0.000 description 1
• JDBJDPGROSVXFC-UHFFFAOYSA-N n-[4-[3-fluoro-4-[5-(1-phenylcyclopropyl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]phenyl]-1-hydroxy-2-(hydroxymethyl)butan-2-yl]acetamide Chemical compound FC1=CC(CCC(CO)(CO)NC(=O)C)=CC=C1C1=NC2=CC=C(C3(CC3)C=3C=CC=CC=3)N=C2S1 JDBJDPGROSVXFC-UHFFFAOYSA-N 0.000 description 1
• YGFLCNPXEPDANQ-UHFFFAOYSA-N n-[bis[(2-methylpropan-2-yl)oxy]phosphanyl]-n-propan-2-ylpropan-2-amine Chemical compound CC(C)N(C(C)C)P(OC(C)(C)C)OC(C)(C)C YGFLCNPXEPDANQ-UHFFFAOYSA-N 0.000 description 1
• 229920001206 natural gum Polymers 0.000 description 1
• 230000001613 neoplastic effect Effects 0.000 description 1
• 208000009928 nephrosis Diseases 0.000 description 1
• 231100001027 nephrosis Toxicity 0.000 description 1
• QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
• 238000013546 non-drug therapy Methods 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
• OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
• 239000008203 oral pharmaceutical composition Substances 0.000 description 1
• 239000007968 orange flavor Substances 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 238000006053 organic reaction Methods 0.000 description 1
• 235000006408 oxalic acid Nutrition 0.000 description 1
• 125000002971 oxazolyl group Chemical group 0.000 description 1
• 125000003566 oxetanyl group Chemical group 0.000 description 1
• 239000007800 oxidant agent Substances 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• 229910052763 palladium Inorganic materials 0.000 description 1
• NXJCBFBQEVOTOW-UHFFFAOYSA-L palladium(2+);dihydroxide Chemical compound O[Pd]O NXJCBFBQEVOTOW-UHFFFAOYSA-L 0.000 description 1
• LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
• YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
• 210000000496 pancreas Anatomy 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
• 239000002245 particle Substances 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 230000035515 penetration Effects 0.000 description 1
• 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 201000002628 peritoneum cancer Diseases 0.000 description 1
• 235000019271 petrolatum Nutrition 0.000 description 1
• 229940066842 petrolatum Drugs 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• 230000003285 pharmacodynamic effect Effects 0.000 description 1
• 239000002831 pharmacologic agent Substances 0.000 description 1
• 239000008196 pharmacological composition Substances 0.000 description 1
• 229960003742 phenol Drugs 0.000 description 1
• 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 239000003495 polar organic solvent Substances 0.000 description 1
• 229960000502 poloxamer Drugs 0.000 description 1
• 229920001983 poloxamer Polymers 0.000 description 1
• 229920001515 polyalkylene glycol Polymers 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
• 229940068977 polysorbate 20 Drugs 0.000 description 1
• 229940068968 polysorbate 80 Drugs 0.000 description 1
• 229920000053 polysorbate 80 Polymers 0.000 description 1
• 229920002451 polyvinyl alcohol Polymers 0.000 description 1
• 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 235000007686 potassium Nutrition 0.000 description 1
• 239000011736 potassium bicarbonate Substances 0.000 description 1
• 235000015497 potassium bicarbonate Nutrition 0.000 description 1
• 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
• 239000001103 potassium chloride Substances 0.000 description 1
• 235000011164 potassium chloride Nutrition 0.000 description 1
• 229960002816 potassium chloride Drugs 0.000 description 1
• NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
• TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
• LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 229960005205 prednisolone Drugs 0.000 description 1
• OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
• 229960004618 prednisone Drugs 0.000 description 1
• XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
• 235000019833 protease Nutrition 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 208000005069 pulmonary fibrosis Diseases 0.000 description 1
• 125000003373 pyrazinyl group Chemical group 0.000 description 1
• 125000002098 pyridazinyl group Chemical group 0.000 description 1
• MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 description 1
• 238000001959 radiotherapy Methods 0.000 description 1
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 238000006722 reduction reaction Methods 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 230000002040 relaxant effect Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 235000019204 saccharin Nutrition 0.000 description 1
• 229940081974 saccharin Drugs 0.000 description 1
• 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
• 229960004889 salicylic acid Drugs 0.000 description 1
• 230000007781 signaling event Effects 0.000 description 1
• 239000000377 silicon dioxide Substances 0.000 description 1
• 238000009097 single-agent therapy Methods 0.000 description 1
• 229960002930 sirolimus Drugs 0.000 description 1
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 1
• 231100000075 skin burn Toxicity 0.000 description 1
• 201000002314 small intestine cancer Diseases 0.000 description 1
• 235000015424 sodium Nutrition 0.000 description 1
• COEZWFYORILMOM-UHFFFAOYSA-M sodium 4-[(2,4-dihydroxyphenyl)diazenyl]benzenesulfonate Chemical compound [Na+].OC1=CC(O)=CC=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 COEZWFYORILMOM-UHFFFAOYSA-M 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• 229960002668 sodium chloride Drugs 0.000 description 1
• AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
• BBMHARZCALWXSL-UHFFFAOYSA-M sodium dihydrogenphosphate monohydrate Chemical compound O.[Na+].OP(O)([O-])=O BBMHARZCALWXSL-UHFFFAOYSA-M 0.000 description 1
• HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
• 229940001584 sodium metabisulfite Drugs 0.000 description 1
• 235000010262 sodium metabisulphite Nutrition 0.000 description 1
• 235000010288 sodium nitrite Nutrition 0.000 description 1
• 239000001476 sodium potassium tartrate Substances 0.000 description 1
• 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
• AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
• 235000019345 sodium thiosulphate Nutrition 0.000 description 1
• 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
• FGXJVJLRSKEONX-UHFFFAOYSA-M sodium;5-(1-phenylethenyl)-[1,3]thiazolo[5,4-b]pyridine-2-carboxylate Chemical compound [Na+].N1=C2SC(C(=O)[O-])=NC2=CC=C1C(=C)C1=CC=CC=C1 FGXJVJLRSKEONX-UHFFFAOYSA-M 0.000 description 1
• 239000011877 solvent mixture Substances 0.000 description 1
• 239000004334 sorbic acid Substances 0.000 description 1
• 235000010199 sorbic acid Nutrition 0.000 description 1
• 229940075582 sorbic acid Drugs 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 235000010356 sorbitol Nutrition 0.000 description 1
• 241000894007 species Species 0.000 description 1
• WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
• 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
• KXCAEQNNTZANTK-UHFFFAOYSA-N stannane Chemical compound [SnH4] KXCAEQNNTZANTK-UHFFFAOYSA-N 0.000 description 1
• 229910000080 stannane Inorganic materials 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 239000008117 stearic acid Substances 0.000 description 1
• 239000012258 stirred mixture Substances 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 239000001384 succinic acid Substances 0.000 description 1
• 235000011044 succinic acid Nutrition 0.000 description 1
• 150000005846 sugar alcohols Polymers 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 230000009885 systemic effect Effects 0.000 description 1
• 229960001967 tacrolimus Drugs 0.000 description 1
• QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
• 239000000454 talc Substances 0.000 description 1
• 229910052623 talc Inorganic materials 0.000 description 1
• 235000012222 talc Nutrition 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 235000002906 tartaric acid Nutrition 0.000 description 1
• 239000011975 tartaric acid Substances 0.000 description 1
• HTYZZXUWPRCEIN-UHFFFAOYSA-N tert-butyl 3-(2-ethoxy-2-oxoethyl)azetidine-1-carboxylate Chemical compound CCOC(=O)CC1CN(C(=O)OC(C)(C)C)C1 HTYZZXUWPRCEIN-UHFFFAOYSA-N 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• 125000000335 thiazolyl group Chemical group 0.000 description 1
• 239000002562 thickening agent Substances 0.000 description 1
• 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 description 1
• 125000000464 thioxo group Chemical group S=* 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 235000010487 tragacanth Nutrition 0.000 description 1
• 239000000196 tragacanth Substances 0.000 description 1
• 229940116362 tragacanth Drugs 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000000844 transformation Methods 0.000 description 1
• 238000002054 transplantation Methods 0.000 description 1
• 150000003626 triacylglycerols Chemical class 0.000 description 1
• 229960005294 triamcinolone Drugs 0.000 description 1
• GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
• 125000001425 triazolyl group Chemical group 0.000 description 1
• XNRCYLDXGFCJNQ-UHFFFAOYSA-N tributyl-[1-(4-fluorophenyl)ethenyl]stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C(=C)C1=CC=C(F)C=C1 XNRCYLDXGFCJNQ-UHFFFAOYSA-N 0.000 description 1
• WNDTVJIGQQRIFH-UHFFFAOYSA-N tributyl-[1-(4-phenylmethoxyphenyl)ethenyl]stannane Chemical compound C1=CC(C(=C)[Sn](CCCC)(CCCC)CCCC)=CC=C1OCC1=CC=CC=C1 WNDTVJIGQQRIFH-UHFFFAOYSA-N 0.000 description 1
• MWKJTNBSKNUMFN-UHFFFAOYSA-N trifluoromethyltrimethylsilane Chemical compound C[Si](C)(C)C(F)(F)F MWKJTNBSKNUMFN-UHFFFAOYSA-N 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• WUUHFRRPHJEEKV-UHFFFAOYSA-N tripotassium borate Chemical compound [K+].[K+].[K+].[O-]B([O-])[O-] WUUHFRRPHJEEKV-UHFFFAOYSA-N 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 229920001664 tyloxapol Polymers 0.000 description 1
• MDYZKJNTKZIUSK-UHFFFAOYSA-N tyloxapol Chemical compound O=C.C1CO1.CC(C)(C)CC(C)(C)C1=CC=C(O)C=C1 MDYZKJNTKZIUSK-UHFFFAOYSA-N 0.000 description 1
• 229960004224 tyloxapol Drugs 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 238000001291 vacuum drying Methods 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
• 238000003260 vortexing Methods 0.000 description 1
• 235000012431 wafers Nutrition 0.000 description 1
• 238000009736 wetting Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 239000009637 wintergreen oil Substances 0.000 description 1
• 238000010626 work up procedure Methods 0.000 description 1
• 230000029663 wound healing Effects 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 239000011592 zinc chloride Substances 0.000 description 1
• 235000005074 zinc chloride Nutrition 0.000 description 1
• WRSWIWOVJBYZAW-UHFFFAOYSA-M zinc;methanidylbenzene;bromide Chemical compound Br[Zn+].[CH2-]C1=CC=CC=C1 WRSWIWOVJBYZAW-UHFFFAOYSA-M 0.000 description 1